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N-Methyl-D-aspartate  (NMDA)  receptors  are  critically  involved  in 
synaptic transmission, neural development and various forms  of neuronal 
plasticity including long-term potentiation (LTP) and long-term depression 
(LTD).  They  are  also  involved  in  the  production  of neuronal  damage 
following excessive activation by glutamate released as a result of hypoxia 
or  ischaemia.  Each  heteromeric  receptor  includes  one  or  two  NRl 
subunits,  at  least two  of the four  NR2A-D  subunits  and less usually the 
NR3AJB  subunits.  This  study  demonstrates  that  the  putative  NR2B 
subunit-containing NMDA receptor antagonist Ro 25-6981  potentiates the 
effects ofNMDA on rat hippocampal slices.  The NR2A subunit antagonist 
PEAQX blocks the effects of NMDA alone and the potentiated response 
following  Ro  25-6981  application.  Furthermore,  Ro  25-6981  was  not 
neuroprotective  as  reported  previously  but  unexpectedly  precipitated 
excitotoxicity.  The potentiating effect of Ro  25-6981  required around 20 
minutes  to  become  apparent,  took  a  further  30  minutes  to  reach  its 
maximum  effect  and  was  irreversible.  It  was  not  prevented  by 
staurosporine (a broad-spectrum protein kinase inhibitor), okadaic acid (a 
potent inhibitor of the serine/threonine protein phosphatases types  1 and 
2A)  or  anisomycin  (a  protein  synthesis  inhibitor).  However,  the 
potentiation  was  prevented  by  cyclosporin  A  (an  inhibitor  of 
Ca
2+/calmodulin-dependent  phosphatase  2B  [calcineurin]).  The  results 
"  :.::2~·,. indicate that in an intact neuronal network, NR2B subunits tonically gate 
NR2A  subunit-containing  receptor  function  by  a  negative  coupling 
mechanism involving ca1cineurin activation. 
NMDA  receptor-dependent  LTP  induced by high  frequency  stimulation 
was prevented by PEAQX, an NR2A antagonist.  Ro  25-6981  was unable 
to prevent L  TP induction but was associated with a marginal reduction in 
the magnitude of  LTP induced. 
There is  evidence for  the binding of homoquinolinic acid to  an NMDA-
insensitive  novel  binding  site  in  the  brain.  This  study  investigated  the 
pharmacology of homoquinolinate on the evoked field excitatory synaptic 
potential (fEPSP) recorded from  the CAl area of rat hippocampal slices. 
Two NMDA receptor agonists, quinolinic acid 150/lM and homoquinolinic 
acid  2.5/lM,  caused  an  approximately  50%  inhibition  of fEPSP  slope. 
Paired-pulse studies suggested there might be a presynaptic component to 
this  action  that  is  independent  of presynaptic  adenosine  Al  receptor 
activation.  The broad-spectrum EAA antagonist kynurenic  acid and the 
NMDA  receptor  blockers  2-amino-5-phosphonopentanoic  acid  and 
dizocilpine  could prevent the  inhibition of fEPSP  slope.  None of these 
antagonists  revealed  any  other  NMDA-insensitive  activity  of 
homoquinolinic  acid.  The  use  of 2-carboxy-3-carboxymethylquinoline 
(CCMQ) to displace the reported NMDA-insensitive binding had no  effect 
on either baseline fEPSP slope or the depression caused by homoquinolinic 
3 acid.  It was  also  apparent that responses  to  homoquinolinic  acid  were 
blocked completely by the NR2A subunit-selective antagonist PEAQX, but 
not by the NR2B subunit-selective blocker Ro 25-6981.  It was concluded 
that the novel binding site for homoquinolinic acid does not affect synaptic 
potentials in the hippocampus and that homoquinolinic acid appears to be a 
selective  agonist  at  NMDA  receptors  that  include  the  NR2A  subunit. 
Although the NR2B agonist site may be maximally activated under normal 
conditions and therefore it is not possible to observe any additional effects 
upon fEPSP slope. 
This  study  next  investigated  the  negative  coupling  between NR2B  and 
NR2A  subunit-containing  receptors,  combining  the  NR2A1B  subunit 
selective  agonist  HQA  with the  NR2B  and NR2A  selective  antagonists 
Ro 25-6981 and PEAQX.  The negative coupling observed previously with 
applications  of  NMDA  was  also  seen  using  HQA  and  QA.  The 
potentiation  of responses  to  HQA by Ro  25-6981  application  was  also 
associated  with  an  enhancement  of  paired-pulse  interactions.  The 
subsequent application of  PEAQX was able to block both the depression of 
fEPSP  slope and the associated enhancement of paired-pulse interactions. 
The presence of a presynaptic element during applications of HQA alone 
and  potentiated  responses  alike  and  the  blockade  of these  effects  by 
PEAQX  suggests  the  NR2A  subunit-containing  NMDA  receptor  is 
responsible for the presynaptic effects acting either directly at presynaptic 
4 sites or indirectly at postsynaptic sites leading to the raising of a retrograde 
signal.  The NR2B subunit in both its activated and antagonised state was 
associated with enhancements  in paired-pulse interactions which suggest 
that it is not able to modulate directly the presynaptic element.  However, 
whilst paired-pulse interactions  are  generally  accepted to  he presynaptic 
phenomena, it does not follow that postsynaptic effects  cannot influence 
the appearance of changes in these interactions in  field recordings.  The 
absence  of any  observable  difference  between  HQA,  QA  and  NMDA 
results suggests that the NR2D subunit is  not obviously involved in these 
processes. 
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22 Chapter 1.  Introduction 
NMDA receptor: an historical perspective 
The excitatory amino acid transmitter field has its historical origins in the 
finding  of the  convulsive  effects  of L-glutamate  and  L-aspartate  upon 
mammalian brain tissue (Hayashi,  1952;  1954) and their depolarising and 
excitatory effects on central neurones (Curtis,  1959;  1960).  However the 
concept that such an amino acid, found in relatively high concentrations in 
the central nervous system (CNS), may be responsible for the majority of 
neurotransmission  only  became  accepted with the  accumulation  of later 
evidence  from  electrophysiological,  pharmacological  and  molecular 
biological studies.  L-glutamate is now considered the principal excitatory 
neurotransmitter in the mammalian CNS acting upon a variety of receptor 
types.  The existence of glutamate receptor subtypes was suggested by the 
observations that glutamate agonist analogues showed different potencies 
on different  subsets  of neurones  (Curtis  &  Johnston,  1974;  McLennan, 
1983).  Furthermore, the development of several antagonists in the early 
1970' s that had differential effects upon agonist responses resulted in an 
initial classification ofNMDA, quisqualate and kainate receptors (Evans et 
ai., 1978; Davies & Watkins, 1979; McLennan & Lodge, 1979; Ault et aI., 
1980).  Since  quisqualate  was  later  shown  to  activate  metabotropic 
glutamate receptors  (Sladeczek et ai.,  1985;  Nicoletti et ai.,  1986)  and a 
23 new  agonist,  a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic  acid 
(AMPA)  (Krogsgaard  Larsen  et  a/.,  1980),  was  demonstrated  to  be 
selective for the quisqualate-activated non-NMDA receptors the ionotropic 
receptor  family  was  reclassified  as  NMDA,  AMP A  and  kainate 
(Collingridge & Lester,  1989).  This  has  since been confirmed with the 
cloning and functional  expression of various NMDA, AMP  A and kainate 
receptor subunits (Hollmann & Heinemann, 1994). 
NMDA receptor physiology 
The  NMDA  receptor  is  a  heteromeric  ligand-gated  ion  channel  that 
interacts with multiple intracellular proteins by way of different subunits 
(McBain  &  Mayer,  1994;  Husi  et  ai.,  2000).  NMDA  receptors  are 
involved in a variety of neural processes, including long-term potentiation 
(LTP)  (Collingridge  &  Singer,  1990;  Bliss  &  Collingridge,  1993),  long-
term depression (LTD) (Dudek & Bear, 1992; Mulkey & Malenka,  1992), 
learning,  memory  (Olney,  1990;  Nakanishi  et  ai.,  1992),  brain 
development,  excitotoxicity  (Choi  &  Rothman,  1990),  neuropathologies 
such as  epilepsy, psychosis and neurodegenerative diseases  (Choi,  1988; 
Greenamyre & Young, 1989; Meldrum &  Garthwaite, 1990; Doble, 1995). 
The NMDA receptor is characterised by a number of unique and important 
properties  that  distinguishes  it  from  other  ligand  gated  ion-channels. 
Firstly,  extracellular  Mg
2
+  at  resting  membrane  potentials  blocks  the 
24 NMDA  receptor  channel  and  it  is  only  opened  with  simultaneous 
depolarisation and agonist binding (Mayer et aI.,  1984).  Secondly, NMDA 
receptor channels  are  highly permeable to  both monovalent  cations  and 
Ca
2+ ions.  NMDA receptor activation results in an influx of  Ca
2+ as well as 
the influx of Na+  and efflux of K+  that is  characteristic of all  excitatory 
amino acid (EAA) ionotropic receptors (MacDermott et at., 1986; Mayer & 
Westbrook,  1987; Schneggenburger et aI.,  1993).  This characteristic Ca
2+ 
entry  is  the  key  trigger  for  many  important  physiological  phenomenon 
including LTP (Lynch et at.,  1983; Bliss &  Collingridge,  1993) and LTD 
(Dudek &  Bear, 1992; Selig et at.,  1995) where the relative magnitude of 
the rise  in  intracellular  Ca
2+ concentration  and  its  temporal  and  spatial 
character determines which plasticity is induced (Lisman,  1989; Artola & 
Singer, 1993; Neveu & Zucker, 1996).  Furthermore, prolonged activation 
of NMDA receptors  results  in excessive Ca
2+ influx producing neuronal 
cell  death in hypoxia,  ischaemia and  neurodegenerative  disorders  (Choi, 
1988).  Thirdly,  the  coincident binding  of glutamate  and  the  co-agonist 
glycine is necessary for receptor activation (e.g. two molecules of glycine 
and  two  molecules  of  glutamate  in  a  tetrameric,  heterodimeric, 
NR11NR11NR21NR2  receptor)  (Johnson  &  Ascher,  1987;  Kleckner  & 
Dingledine,  1988).  Glycine  is  present  in  cerebrospinal  fluid  at  a 
concentration  of about  10~M (Curtis  &  Johnston,  1974)  and  could  be 
expected to  attain  a  similar concentration  in the  extracellular fluid.  At 
these  concentrations  the  NMDA receptor  could  be  fully  saturated  with 
25 glycine, however it is conceivable that glycine is also released from glia or 
from the presynaptic terminal as  a co-transmitter (Davanger et al.,  1994). 
Furthermore, the widespread expression of  mRNA for glycine transporter-l 
throughout  the  brain,  with  a  distribution  colocalized to  that  of the  NRI 
subunit  suggests  that  the  concentration  of glycine  is  closely  regulated 
(Smith  et  al.,  1992).  It has  been  reported  by  some  groups  that  the 
application  of  glycine  potentiates  NMDA  receptor-mediated  synaptic 
transmission (Danysz et al.,  1989;  Wilcox et al.,  1996;  Lim et al.,  2004) 
but not by others (Fletcher & Lodge, 1988; Obrenovitch et al., 1997). 
NMDA receptor molecular biology 
Molecular studies have reported that native rat NMDA receptors may be 
either tetrameric or pentameric membrane proteins comprising the NMDA 
receptor 1 (NR1)  subunit family,  of which there are eight splice variants 
(NRla-h based upon the presence or absence  of 3 exons)  encoded by a 
single gene, and the NR2 subunit family, of which there are four members 
(NR2A-D)  (Laube  et  al.,  1998),  each  encoded  by  four  distinct  genes 
(Seeburg et al.,  1994; Dingledine et al.,  1999).  A third family ofNMDA 
receptor  subunits,  NR3,  has  also  been  described  (Ciabarra  et  al.,  1995; 
Sucher et al.,  1995); of which there are two types NR3A and NR3B that 
less  commonly  contribute  to  NMDA  receptors  (Nishi  et  al.,  2001; 
Chatterton et al., 2002; Eriksson et al., 2002).  The NR3A subunit has been 
26 shown to  function  during  early  development and to  modulate negatively 
ion channel activity (Das et ai.,  1998).  It has been reported that mutations 
in  the  NR2  subunit  alters  the  NMDA  receptor's  response  to  glutamate 
whilst mutations in the NR1  subunit do  not (Laube et ai.,  1997; Anson et 
ai.,  1998;  Anson et ai.,  2000).  This  is  consistent with the  pronounced 
glutamatergic heterogeneity of  the native NMDA receptor being dependant 
upon the NR2A-D subunit complement and the slight heterogeneity seen 
with NR1  splice variants (Buller & Monaghan,  1997).  In particular, the 
presence  of different  NR2A-D  subunits  within  a  heteromeric  receptor 
confers  different  degrees  of  affinity  for  glutamate  and  dictates  the 
functional  properties  of the  receptor  (table2).  Thus,  the  NR2  subunit 
contains  the  glutamate  binding  site  (Laube  et  aI.,  1997)  whilst  the  co-
agonist glycine's binding site is  located on the NR1  and the NR3  subunit 
(Kuryatov  et  aI.,  1994).  Native  heteromeric  receptor  complexes  are 
thought  to  be  combinations  of one  or  two  NR1  and/or  NR3  subunits 
forming the glycine-binding site and two or three NR2 subunits providing 
the glutamate-binding site.  The exact subunit composition influencing the 
NMDA  receptors'  pharmacology  and  function  (Kohr  &  Seeburg,  1996; 
Krupp et ai., 1996; Monaghan & Larsen, 1997; Vicini et ai.,  1998; Pizzi et 
ai.,  1999).  The subunit composition of the NMDA receptor is  dynamic, 
changing  during  synaptic  development  (Kew  et  ai.,  1998a;  Tovar  & 
Westbrook, 1999), synaptic plasticity (Kiyama et ai.,  1998; Manabe et ai., 
2000)  and  other  physiological  and  pathophysiological  processes.  The 
27 activity-dependent  trafficking  of NMDA  receptors  is  achieved  both  by 
receptors recycling through exocytosis-endocytosis from intracellular sites 
and lateral diffusion of receptors between synaptic and extrasynaptic sites 
(Tovar  &  Westbrook,  1999;  Grosshans  et  al.,  2002;  Groc  et al.,  2004; 
Lavezzari et al., 2004). 
NMDA receptor distribution 
Glutamate receptors are predominantly expressed in the CNS, but have also 
been  reported  in  pancreatic  islet  cells,  osteoclasts,  osteoblasts,  nerve 
terminals in the skin,  mast cells,  taste buds,  cardiac ganglia and even in 
plant cells.  The first evidence for differential NMDA receptor distribution 
came  from  electrophysiological  studies  into  the  endogenous  agonist 
quinolinic  acid  (QA),  which  demonstrated  variable potency  in  different 
brain regions (Stone &  Burton,  1988).  In the brain NMDA receptors are 
now known to  be heterogeneously distributed according to  their subunit 
composition, in particular to that of the NR2 family (Monaghan &  Buller, 
1994)  (see table  1).  The NR1  subunit is  expressed throughout the brain 
with little differential distribution of splice variants (Nakanishi et al., 1992; 
Laurie &  Seeburg,  1994)  The NR2A-D subunits are expressed in a very 
distinct  pattern  (Watanabe  et  al.,  1993;  Buller  et  a!.,  1994;  Laurie  & 
Seeburg,  1994).  In  the  adult  brain  the  NR1  and  NR2A  subunits  are 
ubiquitous, the NR2B subunit is expressed mainly in the forebrain, NR2C 
28 is found particularly in the cerebellum and various select nuclei and NR2D 
expression is  limited to  the diencephalon and the mid-brain (McBain & 
Mayer, 1994).  Hippocampal CAl pyramidal cells express mRNA for NRl, 
NR2A, NR2B and NR2D in the adult human (Scherzer et aI., 1997) and the 
juvenile rat (Kirson et aI., 1999). 
NMDA  receptors  have  been  amply  demonstrated  on  the  postsynaptic 
membrane  (Petralia  et  aI.,  1994;  Racca  et  aI.,  2000),  and  there  is 
accumulating evidence suggesting a presynaptic locus.  AMP  A,  mGlu and 
kainate receptors have all been established as presynaptic autoreceptors in 
the hippocampus (Vazquez et aI.,  1994; Chittajallu et al., 1996; Alici et al., 
1997),  modulating  excitatory  transmission  by altering  glutamate  release 
probability.  Immunohistochemical studies have suggested the existence of 
presynaptic NMDA autoreceptors (Liu et al., 1994; Paquet &  Smith, 2000). 
Also,  functional  studies  have reported  evidence  for  presynaptic  NMDA 
receptors  in  the  cerebellum  (Glitsch  &  Marty,  1999),  visual  cortex 
(Sjostrom  et  al.,  2003),  spinal  cord  (Liu  et  aI.,  1997),  hippocampus 
(Breukel et aI.,  1998), suprachiasmatic nucleus (Hamada et aI.,  1998) and 
entorhina1 cortex (Berretta &  Jones, 1996).  Presynaptic NMDA receptors 
have been reported to be NR2B subunit-containing and tonically activated, 
causing an increase in glutamate release probability, dependent upon Ca
2
+ 
influx, in the entorhina1 cortex (Woodhall et aI., 2001). 
29 NMDA receptor development 
Developmentally  only  NR2B  and  NR2D  subunits  are  present  and 
widespread in the prenatal brain but shortly after birth, NR2A and NR2C 
subunits quickly predominate while the NR2B and NR2D subunits decline 
to  adult  levels  and a limited distribution.  NR2B  subunits  are  expressed 
from  late  embryonic  stages up  to  adulthood,  while  expression of NR2A 
subunits  only develops  during  early postnatal stages  and rises  to  mature 
levels by post-natal day 21  (Williams et al.,  1993; Mori &  Mishina,  1995; 
Wenzel et al.,  1995; Portera Cailliau et al.,  1996).  This transformation is 
particularly significant for the age-dependence of synaptic plasticity (Kemp 
et aI.,  2000)  and glutamate toxicity (Liu et aI.,  1996).  NR1  subunits are 
present and  widespread both pre- and post-natally (Lynch  &  Guttmann, 
2001)(see tables 1,2 and 3). 
30 Subunit  Localisation in adult  Developmental 
animals  course 
NRI  Ubiquitous with splice variant  Prenatal and postnatal 
distribution limited to specific 
cells 
NR2A  Widespread throughout the  Develops post-natally 
forebrain.  Less prominent in 
the basal ganglia 
NR2B  Largely limited to forebrain  Widespread with later decline 
to adult levels and 
distribution 
NR2C  Largely limited to cerebellum  Appears postnatally 
NR2D  Isolated cells of  thalamus, sub  Widespread prenatally 
thalamus and nNOS 
containing cells of  cortex 
Table  1.  Summary  of the  distribution  and  developmental  course  of NMDA 
receptor subunits. 
31 NMDA receptor 
Subunit heterogeneity  property 
Glutamate and glycine 
2D > 28> 2C  affinity 
Channel open  2A (2-5 fold higher) > 28  probability 
Peak current density  2A (4 times larger) > 28 
Channel conductance  2A, 28 »  2C, 2D 
Receptor kinetics  2A > 28 =  2C > 2D 
Current decay time  2A > 28 > 2C > 2D 
Ca~'" influx  28 >2A 
Sensitivity to Mg~· 
2A, 28 »  2C, 2D  block 
Deactivation time  2D »  28, 2C > 2A 
Desensitisation  2A »  2D »  28, 2C 
sensitivity 
Speed of recovery from  2A > 2A128 > 28 
desensitisation 
Proton sensitivity  2A > 28 > 20 > 2C 
Table  2.  Summary  of  the  functional  heterogeneity  of  NMDA  receptors 
depending on the presence of specific NR2 subunits. 
32 Widely distributed in mammalian CNS (especially 
NMDA 
enriched in hippocampus and cerebral cortex). 
Widespread in CNS; similar distribution to NMDA 
AMPA 
receptors. 
Concentrated in a few specific areas of  CNS, 
Kainate 
corresponding to NMDA and AMP  A receptor distribution. 
A class of  receptors positively linked to inositol 
Metabotropic 
triphosphate or negatively to cyclic AMP formation. 
Table  3.  Summary of the general  distribution of excitatory amino  acid  (EEA) 
receptors in the mammalian eNS. 
33 NMDA receptor pharmacology 
The  complicated  physiology  of the  NMDA  receptor  complex  provides 
agonists  and  antagonists  with  several  distinct  binding  sites:  glutamate, 
strychnine-insensitive  glycine,  ion-channel,  polyamine  and  other 
modulatory sites (Figure 1). 
Glutamate,  NMDA,  aspartate,  quinolinic  acid,  homoquinolinic  acid  and 
other agonists activate the glutamate site; the prototypic antagonist of this 
site is 2-AP5.  The glycine site is activated by glycine (Johnson & Ascher, 
1987) and several antagonists  exist including ACBC,  CGP  78608 and 7-
chlorokynurenic acid (Fletcher &  Lodge,  1988; Kemp  et al.,  1988).  The 
NMDA receptor ion channel is blocked by Mg2+ ions at resting membrane 
potentials.  Other modulators have also been discovered that block the ion 
channel in a non-competitive manner; notably, dizocilpine (MK 801), PCP 
and ketamine.  Zinc, like other group IIB metal ions produces inhibition of 
the NMDA receptor and is selective at nanomolar concentrations to NR2A 
subunit-containing NMDA receptors  (Paoletti  et al.,  1997).  Polyamines 
such  as  spermine  and  spermidine  can  inhibit  or potentiate  the  NMDA 
receptor, at high and low concentrations respectively.  Polyamines promote 
channel  opening at low micromolar concentrations by glycine-dependent 
and  glycine-independent  mechanisms  (Rock  &  Macdonald,  1992; 
Williams,  1997).  At higher concentrations,  they block the  channel  in  a 
34 voltage-dependent manner.  Antagonists at this site, inhibiting the NMDA 
receptor,  include  ifenprodil  and  haloperidol  (Reynolds  &  Miller,  1989; 
Ilyin et ai., 1996; Lynch & Gallagher, 1996).  Modulation also occurs at the 
Ro  25-6981  site,  the  redox  site  and  with  ethanol  and  the  volatile 
anaesthetics. 
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Figure 1.  The NMDA receptor. 
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A  model  showing the agonist binding  sites for glutamate and  glycine and  the 
competitive  antagonists  that  can  block  these  sites.  Additionally,  other 
modulators  can  block the  ion-channel  and  modulate  the  receptor at discrete 
sites (Kemp & McKernan, 2002). 
36 AMPA and kainate receptors 
The a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMP  A) and 
kainate  (KA)  receptors  are  the non-NMDA ionotropic  receptor subtypes 
that activate Na+ and K+ conductances whilst the NMDA receptors activate 
Na+,  K+ and Ca+ conductances (Monaghan et at., 1989; Barnard &  Henley, 
1990).  AMP A receptors are hetero-oligomeric proteins consisting of the 
subunits  GluR1  to  GluR4,  each  receptor  comprising  four  subunits 
(Hollmann & Heinemann, 1994; Rosenmund et at., 1998).  The AMPA and 
kainate receptors have at least three separate binding sites at which agonists 
and  antagonists  can  act:  glutamate binding,  desensitisation  and intra-ion 
channel binding sites.  Kainate receptors consist of GluR5-7  and KA1-2 
subunits,  and  have  approximately  40%  sequence  homology  to  AMP A 
receptor GluR1-4 subunits.  High affinity binding of kainate is observed to 
the KA1  and KA2 subunits compared to low affinity binding to GluR5-7. 
The same agonists and antagonists can modulate both AMP A and kainate 
receptors  with  little  differentiation.  However,  certain  desensitisation 
inhibitors, which act allosterically to  modulate positively sites on the ion 
channel, can distinguish between AMP  A and kainate receptors (Table 3). 
37 Inhibitory GABA-ergic transmission 
As well as excitatory transmission mediated by glutamate there is also the 
presence of  GABA-ergic interneurones that mediate feedforward and 
feedback inhibition of  excitatory transmission.  Activation of  these 
inhibitory interneurones by glutamate results in a dual component 
inhibitory postsynaptic potential (IPSP)(Alger & Nicoll, 1982; Benardo, 
1994).  This consists of  a GABAA-mediated fast component which results 
in the activation of  GABAA  ionotropic receptors releasing hyperpolarising 
cr  ions into the neurone.  The other component is a slow GABAB -
mediated component which results in the activation of  the GABAB 
metabotropic receptor (Alger, 1984)  leading to the hyperpolarising influx 
of  K+ ions and the negative modulation of  the influx of  Ca
2+ ions.  IPSPs 
can inhibit excitatory synaptic transmission by moving the membrane 
potential to values that are more negative and increasing the amount of 
depolarisation required by EPSPs to reach the threshold for action potential 
generation.  GABAB  mediated slow IPSPs are possibly better poised to 
counter longer-lasting EPSPNMDA which because of  their long slow kinetics 
have been reported to escape fast GABAA  inhibition (Benardo, 1995) 
although one report suggested that when stimulation evokes only a small 
EPSP (2-5m  V) the GABAB component is negligible (Otmakhova & 
Lisman,2004).  In addition to postsynaptic GABA receptors there is also a 
presynaptic GABAB autoreceptor in the Schaffer collateral feedforward 
38 interneurones (but not in the perforant pathway).  When the interneurone is 
repeatedly activated, GABA is released in sufficient quantity to feedback 
on these GABAB receptors, which inhibits the release of  further GABA, 
and synaptic inhibition is depressed (Davies et al., 1990). 
39 Excitotoxicity 
The term excitotoxicity was first coined by John Olney who observed that a 
number  of  excitatory  amino  acids  (EAAs)  killed  neurones  in  the 
hypothalamus  with  a  potency  that  correlated  with  their  efficacy  in 
depolarising cells.  Excitotoxicity is  a critical mechanism contributing to 
neurodegeneration during ischaemia and hypoxia.  Both the loss of calcium 
homeostasis  and  the  activation  of EAA  receptors  are  postulated  to  be 
responsible for  excitotoxic neuronal  damage (Olney,  1969;  1986;  Seisjo, 
1988;  Choi,  1991;  Sattler et al.,  1999).  With the activation of NMDA, 
receptors  both  of these hypotheses  are  fulfilled.  The over-activation of 
NMDA  receptors  leads  to  an  influx  of Ca
2
+  resulting  in  necrosis  or 
apoptosis by several proposed mechanisms.  The subsequent activation of 
Ca
2
+ -sensitive  enzymes  (nNOS,  endonucleases  and  proteases),  the 
production  of  highly  reactive  free  radical  species,  mitochondrial 
impairment and the activation of immediate-early response sense genes all 
contributing  to  neuronal  death.  Blockade  of this  influx,  by  NMDA 
antagonists and calcium antagonists, is neuroprotective in animal models of 
stroke and  seizure  (Lee  et  aI.,  1999).  The  clinical use of non-selective 
NMDA  receptors  as  neuroprotective  drugs  has  been  hindered  by  their 
narrow  therapeutic  window,  which  produces  adverse  drug  reactions 
including  sedation,  muscular  weakness,  ataxia,  confusion  and  tinnitus. 
Subunit selective antagonists such as ifenprodil have been associated with a 
40 decrease in side effects allowing an effective therapeutic dose to be titrated 
(Gotti et aI.,  1988).  Nevertheless, therapeutic NMDA receptor antagonists 
have yet to  be developed with clinical success  (De Keyser et at.,  1999). 
Several  studies have specifically implicated both the NR2A- and NR2B-
containing NMDA receptors in excitotoxicity.  Excitotoxicity in cultured 
embryonic forebrain neurones coincides with a dramatic increase in NR2B 
mRNA levels during the first  10  days, thereafter remaining stable (Cheng 
et aI.,  1999).  However, decreased expression of NR2A and NR2B mRNA 
has also been reported in CAl and other hippocampal areas, in response to 
a  severe  ischaemic insult,  altering  the  function  of the  NMDA  receptors 
(Zhang  et  aI.,  1997).  In  addition  to  changes  in  subunit  expression, 
ischaemia has also been shown to increase the tyrosine phosphorylation of 
both the NR2A and NR2B subunits thereby altering their function (Kim et 
at., 1998; Cheung et at., 2000). 
41 Anatomy of the hippocampus 
The electrophysiological experiments described in this study were carried 
out in the hippocampal slice preparation of the 7-8  week old Wistar rat. 
The hippocampus along with the amygdala, adjacent regions of the limbic 
cortex  and  the  septal  area  constitute  the  main  structures  of the  limbic 
system.  These structures form major interconnections with portions of the 
thalamus and the cerebral cortex (cingulated gyrus). 
For three reasons  the  hippocampus  is  one  of the most  studied  areas  of 
central nervous system.  Firstly, it has an easily identifiable structure at the 
gross  and histological  levels.  Secondly,  it has  been recognized that the 
hippocampus plays a fundamental  role in learning and memory (patients 
who  have  had  bilateral  hippocampalectomy  have  suffered  from  a 
permanent loss of storing new information into their long-term memory). 
Thirdly, the hippocampus is especially susceptible to  seizure disorders and 
is particularly vulnerable to the effects of ischaemia and hypoxia (Johnston 
& Amaral, 1998). 
In  the  brains  of mammals,  the  hippocampus  is  a bilateral  structure that 
appears as a ridge extending into the lateral ventricle.  The outer surface of 
the hippocampus is  composed of myelinated fibres,  appears white and is 
called  the  alveus.  The  hippocampal  formation  can  be  divided  into 
Ammon's hom, the subiculum, the dentate gyrus and the entorhinal cortex. 
42 Based on the Golgi method of staining, the anatomist Lorente de N6 (1934) 
(see Johnstone  &  Amaral,  1998)  divided Ammon's hom into  four  cornu 
Ammonis subfields: CAl to CA4.  The designation CA4 is no longer used 
because it referred to the region occupied by the polymorphic layer of the 
dentate gyrus.  CAl is equivalent to the regio superior and CA2 and CA3 
fields are equivalent to the regio inferior.  A narrow transitional zone, CA2, 
separates CAl and CA3 (Figure 2). 
The dentate gyrus  contains round,  tightly packed neurons  called granule 
cells and consists of three layers: the granule layer, which is the principal 
layer, the molecular layer above the granule cell layer and a polymorphic 
layer below the granule cell layer (Isaccson, 1987). 
In all CA fields below the alveus is the stratum oriens, which contains the 
basal dendrites of the pyramidal cells.  The cell bodies are clearly visible 
under a microscope  as  a dark band.  Below this  is the  stratum radiatum 
consisting of the apical dendrites of the pyramidal cells and the Schaffer 
collaterals, which are collateral branches from axons of pyramidal cells in 
the CA3 region (Cajal, 1968). 
43 Neuronal circuits in the hippocampus 
The  excitatory  neuronal  circuitry  of  the  hippocampal  formation  is 
illustrated in figure 2.  The functional organisation of  the hippocampus has 
been described in terms of a 'trisynaptic' circuit.  Information that flows 
from  the  neocortex  into  and  out  of  the  hippocampus  travels  in  a 
unidirectional  manner through  this  trisynaptic  pathway.  The  entorhinal 
cortex is considered the starting point of the circuit.  Neurones located in 
layer II  of the  entorhinal  cortex  give  rise  to  the  perforant pathway that 
projects through the subiculum and terminates both in the dentate gyrus and 
in the CA3 region.  Neurones forming the medial entorhinal cortex produce 
axons  that  terminate  in the  middle  layer  of the  molecular  layer  of the 
dentate gyrus; the outer third of  the molecular layer receive axons from the 
lateral entorhinal cortex.  These two components of the perforant pathway 
also  terminate in the  stratum lacunosum-molculare of the CA2 and CA3 
regions.  N  eurones located in layer III of  the entorhinal cortex proj ect to the 
CA 1 and the subiculum. 
The granule  cells  also  synapse  onto  neurones  of the polymorphic  layer, 
which  supplies  associational  connections  to  other  levels  of the  dentate 
gyrus.  The CA3 pyramidal cells project heavily within the CA3 and as the 
Schaffer  collateral  projection to  the  CAl  stratum  radiatum  and  stratum 
oriens.  CAl neurones project to both the subiculum and the deep layers of 
44 the entorhinal cortex, which in turn produce projections back into many of 
the  cortical  areas  that  originally  terminated  in  the  entorhinal  cortex. 
Therefore information sent from cortical neurones to the entorhinal cortex 
can then negotiate the complete hippocampal circuit and be returned back 
to its cortical origin (Witter, 1989). 
As well as the main excitatory circuitry, there are also inhibitory pathways 
throughout  the  hippocampus.  Three  types  of interneurones  control  this 
circuit  in  the  pyramidal  cell  layers:  axo-axonic  cells,  basket  cells  and 
bistratified cells.  The majority of  interneurones in the hippocampus use the 
inhibitory transmitter y-aminobutyric acid (GABA).  The axo-axonic cells 
synapse upon the initial segment of pyramidal neurones and have a strong 
influence  over the  generation of action potentials.  Basket cells  synapse 
onto the somata and bistratified cell synapse at apical and basal dendrites of 
the  pyramidal  neurones.  The  dendrites  of  these  three  classes  of 
interneurone proj ect  into the stratum radiatum and  stratum  oriens where 
they  can  encounter  excitatory  inputs  from  the  Schaffer  collaterals, 
commissural-association  fibres  and  feedback  synapses  from  local 
pyramidal neurones (lsaccson, 1987; Johnston, 1998). 
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Figure 2.  Diagram showing the anatomy of the rat hippocampal formation and 
the placement of the stimulating and recording electrodes. 
A,  location of the left hippocampus in  rat brain.  B,  structure of a hippocampal 
slice showing  the  principal  excitatory neurons.  The  stimulating  electrode (1) 
was positioned in  the stratum radiatum at the CA1/CA2 junction.  Orthodromic 
population spikes and excitatory postsynaptic potentials were recorded from the 
stratum pyramidale and stratum radiatum respectively using electrodes (2) and 
(3)  placed  in  the CA  1 region.  C,  hippocampal circuitry.  DG,  dentate gyrus; 
ENT,  entorhinal  cortex;  mf,  mossy fibre;  pp,  perforant pathway;  rc,  recurrent 
collateral; sc, Schaffer collateral; SUB, subiculum.  (Revest & Longstaff, 1998). 
46 The hippocampal slice preparation 
Ever since cortical slices were demonstrated to have comparable electrical 
activity with the intact  animal  (Yamamoto  &  McIlwain,  1966)  the  slice 
preparation has been used extensively in the study of synaptic transmission 
and electrophysiological experiments in the mammalian CNS.  The studies 
leading  to  our  present  understanding  of  how  NMDA,  AMP  A,  and 
metabotropic glutamate receptors contribute to  synaptic transmission;  and 
investigations of LTD and L  TP have come almost exclusively from brain 
slice  studies.  Hippocampal  slices  have  also  shown  good  conditions  to 
allow  intracellular  recording  (Yamamoto,  1972;  Kerkut,  1981).  The 
hippocampus  is  an  essentially  laminar  structure,  each  transverse  slice 
having the same 'trisynaptic' circuitry.  The neuronal function and anatomy 
of the slice preparation, in the plane in which it is cut, is calculated to be 
similar to the intact brain producing representative electrophysiological and 
pharmacological responses.  The slices should be well enough prepared to 
allow recording at physiological temperatures (36-37°C  for rodent slices) 
however, this is not usually achievable and a sub-physiological temperature 
of  28-30°C is normally used. 
47 Advantages  of the  In  vitro  slice  preparation  over  III  VIVO  techniques 
include: 
1.  Technical simplicity:  it is relatively easy to record via extracellular, 
intracellular  and  whole-cell  patch-clamp  compared  with  in  vivo 
experiments. 
2.  Control over the conditions of  the preparation.  If one can reduce the 
number of contributory variables, greater significance can be drawn 
upon  results  from  a  constant  environment  (e.g.  temperature, 
movement,  02/C02  saturation,  absence  of  the  influence  of  an 
anaesthetic maintenance dose). 
3.  Improved  visualization  of tissue.  The  tissue  is  easily  identified 
under low magnification facilitating  the positioning of stimulating 
and recording electrodes. 
4.  Control of the  extracellular environment and the  field  potential to 
study  neurophysiology  and  pharmacology.  This  is  helpful  when 
applying  drugs  and  doses  that  are  impractical  in  whole  animal 
studies. 
5.  Humane  treatment  of animals,  because  slice  preparation does  not 
require restraint or the maintenance of physiological functions it is a 
relatively more humane method. 
48 6.  The ability to use technically demanding methods that are difficult or 
impossible in intact preparations.  For example, the ability to isolate 
specific  pathways  and  record  from  specific  postsynaptic  cells 
without  contamination  of other  synaptic  inputs  from  other  brain 
regions which have been dissected (Grover &  Teyler,  1990), or the 
ability to use optical techniques. 
These advantages of  the slice preparation have led to increasing numbers of 
neuroscientists  to  use  this  technique.  However,  there  are  also  some 
disadvantages with brain slice preparations: 
1.  The dissection and slicing process severs the hippocampal slices' 
normal  sensory  input  and  motor  output.  Long  feedback  loops, 
some excitatory pathways and  some inhibitory pathways are  also 
lost.  One obvious symptom of this is the markedly lower levels of 
spontaneous activity found in the slice preparation compared to the 
intact animal.  This brings into question the similarity and relevance 
of  the  in  vitro  slice  preparation  compared  to  the  in  VIVO 
environment.  Furthermore,  it  has  been  demonstrated  that 
phenomena  such  as  LTD  induction  are  more  readily  induced  in 
vitro than in vivo (Bear & Abraham, 1996) 
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slice, this results in cell damage and the release of substances that 
may affect the slice. 
3.  The tissue is subject to an anoxic period during preparation (Lipton 
& Whittingham, 1979). 
4.  The  ionic  environment  does  not  mImIC  exactly  the  normal 
extracellular conditions in vivo.  This is of particular relevance in 
the induction and maintenance of LTD and L  TP that are dependent 
upon relative ci+ and Mg
2
+ ion concentrations.  The continuous 
perfusion of artificial cerebrospinal fluid (ACSF) can also wash out 
any  modulatory  compounds  endogenous  to  the  slice  (such  as 
growth factors released following stimulation). 
5.  The addition of drugs to  the artificial cerebrospinal fluid  (ACSF) 
results  in  the  exposure  of the  whole  slice  to  pharmacological 
modulation.  This confounds the significance of results seen with 
the subset of cells that are being recorded. 
6.  Finally, the diversity of  methods used in each brain slice laboratory 
makes  the  comparison of findings  difficult  (Lipton et  aI.,  1995). 
The most obvious differences include: (A) the maintenance of  brain 
slices  at  the  interface  of the  ACSF  and  oxygenated  atmosphere 
50 versus those maintained entirely submerged in ACSF,  (B)  cutting 
brain slices  on  a manual  tissue  chopper versus  a vibratome or a 
vibraslice,  (C)  differing  ACSF  recipes  and  (D)  temperature 
differences. 
Extracellular responses 
Single  electrical  stimulations  of  the  Schaffer  collaterals  result  in  a 
distinctive sequence of excitation followed by inhibition in the target CAl 
pyramidal neurones.  Field extracellular recordings represent the summed 
responses from a population of neurones close to  the recording electrode. 
The field excitatory postsynaptic potential (fEPSP) recorded in the stratum 
radiatum  consists  of an  initial  fibre  volley  of action  potentials  in  the 
presynaptic fibres producing a negative-going transient; this is followed by 
a slower negative-going potential with a time-period similar to that of the 
underlying  synaptic  currents.  The  current  flowing  into  these  dendrites 
during  the  fEPSP  will  exit the  neurons  near the  cell  body  layer in  the 
stratum pyramidale where a recording  electrode will  record a concurrent 
positive going potential.  If  the strength of  the synaptic input is adequate to 
evoke  action  potentials  in the  neurons,  then  a  negative-going  potential 
(population spike) can also be recorded in the stratum pyramidale resulting 
from the inward current during the postsynaptic action potentials. 
51 Paired-pulse interactions 
The magnitude of synaptic transmission in the mammalian brain can be 
modulated  in  different  ways.  Two  examples  of such  modulation  are 
paired-pulse facilitation (PPF) and paired-pulse depression (PPD). 
Paired-pulse facilitation 
Paired-pulse facilitation (PPF) is  a form  of short-term plasticity in which 
the synaptic response to  the test pulse (second stimulus)  given  after the 
conditioning  pulse  (first  stimulus)  is  enhanced  in  comparison  to  the 
conditioning  pulse  when  interstimulus  intervals  are  relatively  long 
(~20ms).  The most widely accepted hypothesis to explain the mechanism 
of PPF  is  based on the  accumulation of presynaptic ci+ after the  first 
stimulation.  The  first  pulse  induces  a  Ca
2
+  influx  that  lingers  in  the 
presynaptic terminal for several hundred milliseconds.  This residual Ca
2
+ 
combined with fresh  Ca
2
+  entering  during  the  second pulse leads  to  the 
increased  transmitter  release  (Katz  &  Miledi,  1968;  Thomson,  2000; 
Zucker & Regehr, 2002).  The Ca
2
+ concentration in the presynaptic nerve 
terminal  affects  directly  the  release  probability  of  neurotransmitter. 
Furthermore, reports at the neuromuscular junction have suggested that the 
second of the two  action potentials induces release with higher probability 
than  the  first  one  because  of a  small  but  persistent  increase  of the 
intracellular Ca
2+ concentration in the axon terminal.  This residual  Ca
2
+ 
52 can enhance the release probability by increasing the  fusion  of synaptic 
vesicles  with  the  presynaptic  membrane  and  enhancing  the  number  of 
vesicles released by the action potential (Katz &  Miledi, 1968; Mennerick 
&  Zorumski,  1995;  Debanne  et  at.,  1996).  Neuromodulators  and 
physiological processes that alter transmitter release probability also affect 
the paired-pulse ratio.  Increasing the external Mg
2+/Ca
2+ ratio (Davies & 
Collingridge,  1993;  Lambert  &  Wilson,  1994;  Wilcox  &  Dichter,  1994) 
and  applying  adenosine  (Lupica  et at.,  1992;  Higgins  &  Stone,  1995) 
decreases  the  probability  of release  of neurotransmitter  during  the  first 
stimulus  and increases the  probability of release by the second stimulus 
producing enhanced PPF.  In the hippocampus, PPF of excitatory synaptic 
potentials in the CAl and CA3 is observed when large numbers of axon are 
concurrently  stimulated  (Creager  et  at.,  1980;  Manabe  et  at.,  1993) 
whereas, during conditions in which the release probability is enhanced by 
decreasing the Mg
2+/Ca
2+ ratio then PPF is  reduced (Nathan et at.,  1990; 
Kahle & Cotman, 1993). 
Paired-pulse depression 
When two evoked potentials are  elicited when interstimulus intervals are 
small «1  Oms),  the size of the second response is  smaller than the first,  a 
phenomenon  called  paired-pulse  depression  (PPD).  The  mechanism 
underlying PPD of synaptic transmission is unclear.  One hypothesis is the 
activation  of GABAB  autoreceptors  (Deisz  &  Prince,  1989),  but  studies 
53 have  shown that  GABAB  receptor antagonists  did  not  attenuate  PPD  of 
unitary  inhibitory  post  synaptic  potentials  (IPSPs)  in  pairs  of cultured 
hippocampal neurons (Wilcox & Dichter, 1994). An alternative presynaptic 
mechanism for PPD is a transient decrease in the quantal content caused by 
depletion  of the  readily  releasable  vesicle  pool  by  the  first  stimulus 
(Mennerick &  Zorumski,  1995;  Stevens  &  Wang,  1995;  Debanne et al., 
1996).  Postsynaptic mechanisms  such as  the  desensitisation of GABAA 
receptors  (Alger,  1991)  and  a reduced  driving  force  due  to  intracellular 
accumulation  of  chlorine  ions  and/or  extracellular  accumulation  of 
potassium ions may also  explain PPD  (McCarren &  Alger,  1985).  Since 
paired-pulse  depression  is  observed  most  clearly  and  reliably  when  the 
interstimulus interval is around 15-100 ms, which corresponds to the time 
course  of  the  GABAA  mediated  fast  inhibitory  potential  recorded 
intracellularly in pyramidal cells (Davies et al.,  1990), it is thought to be 
largely caused by the activation of GABAA  receptors (Wilcox &  Dichter, 
1994).  It is  difficult  to  test  this  proposition  using  bath  application  of 
GABAA  receptor  antagonists  such  as  bicuculline  which  increase  the 
excitability of  the pyramidal cells by blocking the effects of spontaneously 
released GABA. 
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to  presynaptic alterations in release probability;  when studied on fEPSPs 
and especially where there are depolarisation-induced changes in the size 
of the postsynaptic potential in  response to  the test agents  many factors 
affect them which can confound the interpretation.  These include changes 
in presynaptic release probability (Andreasen & Hablitz, 1994), activity of 
presynaptic autoreceptors on inhibitory or excitatory terminals (Davies et 
at.,  1990;  Stanford et at.,  1995), modulation of postsynaptic conductances 
(e.g. voltage-dependent NMDA receptor) and the presence of GABA-ergic 
inhibition following the fEPSP and the depression cause by NMDA agonist 
action  (Duguid  &  Smart,  2004).  In particular,  it has  been reported that 
there  is  a non-linear inverse relationship  between feedforward  inhibition 
and  the  NMDA  dependent  PPF  component  of  the  fEPSP 
(Papatheodoropoulos  &  Kostopoulos,  1998)  although,  this  NMDA-
component  of PPF  is  manifested  by  an  increase  in the  duration  of the 
fEPSP and not the amplitude of  the slope. 
In  hippocampal  slices  paired-pulse  inhibition  has  been  reported  at 
interstimulus intervals less than 40 ms and in the present experiments at 
less than 20 ms while PPF is observed at longer time intervals (20 and 50 
IDS) (Lynch et at., 1983; Higgins & Stone, 1995; Nikbakht & Stone, 2000). 
55 Aims 
1.  To investigate NMDA receptor subunit pharmacology in the intact, 
adult  hippocampal  slice  preparation  using  the  newly  developed 
NR2A  and  NR2B  subunit-selective  NMDA  receptor  antagonists 
Ro 25-6981 and PEAQX. 
2.  To address the contribution of NR2A and NR2B subunit-containing 
NMDA receptors  in the  induction of NMDA receptor  dependent 
synaptic plasticity in the Schaffer collateral-CAl pyramidal synapse. 
3.  A report had suggested that the NR2AJ2B subunit selective NMDA 
receptor  agonist  homoquinolinic  acid  was  binding  to  a  novel 
NMDA-insensitive  site  in the brain.  An investigation of NMDA 
insensitive  effects  on  the  fEPSP  was  undertaken  to  reveal  any 
residual effects. 
Furthermore,  the  selectivity  of homoquinolinic  acid  allowed  the 
investigation of the NR2A and NR2B components of the previous 
study  (1)  and to  find  evidence for the involvement of the NR2D 
subunit.  In addition, this study investigated changes of  paired-pulse 
interactions using these compounds. 
56 Chapter 2.  Material and methods 
Preparation of hippocampal slices 
Male  Wistar  rats  (130-180g,  7-8  weeks)  were  anaesthetised  by  an 
intraperitoneal injection of urethane solution (1.5 g/Kg); urethane has been 
shown  not  to  interfere  with  synaptic  plasticity,  a  problem  encountered 
when using phenobarbitone (unpublished observations).  The animals were 
then killed by cervical dislocation, decapitated using a guillotine, and the 
brain  gently  and  rapidly  removed  to  ice-cold  and  oxygenated  artificial 
cerebrospinal fluid (ACSF).  The intact brain was kept cold and moist by 
copious  amounts  of ACSF whilst it was  transferred to  a petri dish lined 
with filter paper to prevent sliding.  The cerebellum was removed and the 
two  cerebral  hemispheres  were  separated  with  a  scalpel  blade.  Each 
hippocampus was dissected free  from  the surrounding tissue using small 
spatulas and cut transversely using a McIlwain tissue chopper into  slices 
450~m thick,  perpendicular to  their  longitudinal  axis.  The  slices  were 
gently  separated  from  each  other  using  blunt  glass  microelectrodes  to 
ensure that they receive adequate amounts of oxygen and nutrients and to 
allow individual slices to be transferred easily.  The slices were incubated 
at  room  temperature  (21-23
0C)  on  a  fresh  filter  paper  lined  petri  dish 
containing a small amount of freshly gassed ACSF to cover the slices.  The 
petri dish was kept in an incubation chamber saturated in an atmosphere of 
57 95% O2  and 5% CO2  for  at  least  1 hour prior to  individual slices being 
transferred to the recording chamber. 
Composition of ACSF 
The composition of the ACSF was (in mM): KH2P04 2.2, KC12, NaHC03 
25, NaCll15, CaCh 2.5, MgS04 1.2, and glucose 10.  It was gassed with a 
mixture of95% O2 and 5% CO2 yielding a pH ,..,7.4. 
Bath superfusion and application of drugs 
Following  incubation,  individual  slices  were  transferred  to  a  I  ml 
submerged recording chamber using a wide tipped plastic Pasteur pipette. 
A seeker wire, the end of  which was modified in such a way as to form a ~ 
shape was used to  gently hold the  slice in place.  The slice was left to 
stabilise whilst being continuously superfused with ACSF by a gravity-fed 
silicone tube at a rate of  4 ml/min.  The ACSF was kept saturated with 95% 
O2  and 5% CO2  and heated using a thermostatically controlled water bath 
to  28-30°C.  Drugs were added to the ACSF and fed via a three-way tap 
through the silicon tubing to the recording chamber.  Due to the length of 
tubing,  it took  1 minute  for  fluid  to  reach the recording  chamber.  To 
prevent the build-up  of organic  matter the  silicon tubing  and  recording 
chamber  were  flushed  with  distilled  water  before  and  after  use. 
Additionally,  the  system  was  more  aggressively  cleaned  using  diluted 
58 bleach  once  a  month  and the tubing  replaced  every  six  months  and  as 
required. 
Stimulation 
Stimuli were AC  amplified square wave constant-current pluses of 300~s 
duration.  Paired  stimuli,  where used,  were  delivered through the  same 
electrode.  The slices were stimulated using a concentric bipolar electrode 
(Clark Electromedical Instruments Ltd,  Harvard Apparatus) positioned in 
the  stratum  radiatum  near  the  commissural  border  of CAlICA2  for 
orthodromic  activation  of pyramidal  cells.  The  slice  was  briefly  and 
occasionally stimulated at I Hertz (Hz) until a population of neurones was 
identified;  once  this  was  achieved,  a  stimulus  frequency  of 0.05Hz  was 
used.  The  population  of  neurones  was  then  allowed  to  stabilise. 
Population  spikes  were  recorded  at  70%  of maximum  amplitude  whilst 
ffiPSP  slopes were recorded at 50% of their maximum amplitudes.  Only 
field  responses  that  produced  clear  ffiPSP  and  population  spikes  with 
maximum  amplitudes  greater  than  2m  V  were  used  in  experiments. 
Furthermore,  responses  that  showed  greater than  5%  drift  over the  20-
minute baseline-recording period were excluded (Figure 3). 
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Figure  3.  Example  responses  recorded  from  the  CA  1  region  of  the  rat 
hippocampal slice. 
Trace (A) shows a population spike recorded from the stratum pyramidale and 
trace (8) shows a fEPSP, recorded from the stratum radiatum. 
60 Recording 
Extracellular population spike potentials and field excitatory postsynaptic 
potentials  (fEPSPs)  were  recorded  extracellularly  from  the  stratum 
pyramidale and the stratum radiatum, respectively, using borosilicate glass 
microelectrodes,  which  were  produced  on  a  Kopf vertical  puller.  The 
electrode tips were broken back to produce an opening 2-4~m  in diameter 
under low magnification using a glass probe, resistances approximately 2-
5MQ.  The electrodes were filled with sodium chloride 0.9% solution using 
a fine 36-gauge needle. 
Evoked responses were amplified through a Neurolog system, displayed on 
a  digital  oscilloscope  and  recorded  onto  a  personal  computer  via  a 
Cambridge  Electronic  Device  (CED)  micro  1401  interface  and  Signal 
analysis  software  (Cambridge Electronic Design,  version  1).  Responses 
were  filtered  between  DC  and  5kHz;  line  frequency  interference  was 
removed by digitally filtering (Humbug, Digitimer Ltd). 
61 Data analysis 
Responses were quantified as the amplitude of the population spike in m  V 
(measured  as  the  difference  between  peak  negativity  and  the  averaged 
values of the two peaks of the positive-going synaptic potential) and the 
fEPSP  was measured as  the maximum slope of the initial negative going 
gradient with two static cursors using Signal software; manually selecting 
and recording the slope in response to  changes in the size of the fEPSP 
response and electrical interference (figure 3).  Individual responses were 
measured,  normalised  and  compared  to  the  20-minute  initial  baseline 
recordings.  Every  time  point  was  pooled  and  graphed using  GraphPad 
Prism  software  (GraphPad  Prism  Software,  San  Diego,  CA,  version  3) 
showing  mean  ±  standard  error  of the  mean  (s.e.m.).  Rarely,  single 
responses  had  to  be  excluded  due  to  anomalous  electrical  interference 
disrupting the recording of  evoked responses. 
When paired-pulse interactions were investigated, inhibition or facilitation 
was expressed as the ratio of the second response of a pair compared with 
the first response. 
Statistical analysis 
The statistical significance of a difference was assessed on raw data by a 
paired  Student's  t-test  or,  if the  difference  was  between  three  or more 
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analysis  of variance  (ANOV  A)  followed  by  a  Student-Newman-Keuls 
post-test  using  GraphPad  Prism  software;  p  values  less  than  0.05  were 
considered statistically significant.  IC50 and EC50  values were calculated 
using  GraphPad  Prism  software  by  generating  non-linear  regression, 
sigmoidal  concentration-response  curves.  In  the  figures  statistically 
differences  between  data  points  are  sometimes  indicated  by  asterisks: 
* p<0.05; ** p<0.01; *** p<O.OOl. 
Chemical agents and drugs 
Constituents of ACSF were of analar grade and were dissolved in distilled 
water to  prepare  fresh  every  day.  N-Methyl-D-aspartic  acid  (NMDA) , 
D-(-)-2-amino-5-phosphonopentanoic acid (2-AP5), dizocilpine (MK 801), 
zinc acetate (Zn
2+),  (RS)-AMPA hydrobromide (AMP A) and kainate (KA) 
were dissolved in distilled water to obtain stock solutions.  Quinolinic acid 
(QA)  and  homoquinolinic  acid  (HQA)  were  dissolved  in  1  molar 
equivalencies  of NaOH  to  give  stock  solutions.  Dimethyl  sulphoxide 
(DMSO)  was  used  to  dissolve  kynurenic  acid  (KYA) ,  2-carboxy-3-
carboxymethylquinoline (CCMQ),  okadaic acid (OA),  anisomycin, (R:(*), 
S:(*))-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethy1)-1-
piperidinepropanol (Ro 25-6981),  staurosporine (STA) and 1,3-dipropyl-8-
cyclopentyl-xanthine  (DPCPX)  to  produce  stock  solutions.  The  final 
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to  slices;  furthermore,  control  applications  of DMSO  0.1%  alone had no 
effect compared to  baseline field recordings.  Cyclosporin A  (CyA)  and 
(R)-[(S)-I-(  4-bromo-phenyl)-ethylamino  ]-(2,3-dioxo-l ,2,3,4-
tetrahydroquinoxalin-5-yl)-methyl]-phosphonic  acid  (PEAQX)  were 
dissolved in ethanol. 
The  majority  of drugs  were  obtained  from  Tocris  Cookson  Ltd,  analar 
grade compounds were obtained from BDH chemicals Ltd.  UK.  NMDA 
was obtained from Sigma chemical Co. Ltd.  Ro  25-6981 was a gift from 
Dr Georg J  aeschke of F.  Hoffmann-LaRoche AG Roche pharmaceuticals 
and  PEAQX  was  a  gift  from  Dr  Yves  Auberson  of  Novartis 
Pharmaceuticals (table 4). 
Compound  Supplier  Stock solution 
NMDA  Sigma chemical Co. Ltd  H2O 
2-AP5  Tocris Cookson Ltd  H2O 
MK801  Tocris Cookson Ltd  H2O 
AMPA  Tocris Cookson Ltd  H2O 
kainate  Tocris Cookson Ltd  H2O 
quinolinic acid  Tocris Cookson Ltd  NaOH 1M equivalencies 
homoquinolinic acid  Tocris Cookson Ltd  NaOH 1M equivalencies 
CCMQ  Tocris Cookson Ltd  DMSOO.1% 
kynurenic acid  Tocris Cookson Ltd  DMSOO.1% 
okadaic acid  Tocris Cookson Ltd  DMSOO.1% 
.  . 
Tocris Cookson Ltd  DMSOO.1%  amsomycm 
Ro 25-6981  F. Hoffinann-LaRoche  DMSO O.l% 
staurosporine  Tocris Cookson Ltd  DMSOO.1% 
DPCPX  Tocris Cookson Ltd  DMSOO.1% 
cyclosporin A  Tocris Cookson Ltd  Ethanol 
PEAQX  Novartis Pharmaceuticals  Ethanol 
Table  4.  List  of  pharmacological  agents,  suppliers  and  solvents  used  to 
produce stock solution. 
64 Chapter  3.  The  negative  coupling  of  NR2B  to 
NR2A subunit-containing receptors. 
Introduction 
There has been a considerable amount of research over the last  10  years 
that  has  identified  the  NR2B  subunit  as  being  especially  important  in 
determining the function of the NMDA receptor.  For example, in forming 
the glutamate binding site (Laube et aI.,  1997), controlling the Mg2+ block 
(Williams et al.,  1998) and in a variety of phenomena including learning 
and memory formation,  synaptic plasticity (Hrabetova et  aI.,  2000), pain 
(Chizh  et  aI.,  2001),  schizophrenia (Grimwood  et aI.,  1999;  Gao  et al., 
2000), Parkinson's disease (Nash et al., 1999; Oh et al., 1999; Dunah et al., 
2000; Steece Collier et al., 2000), Huntington's disease (Chen et al.,  1999; 
Zeron et al.,  2001) and excitotoxicity (Zhang  et al.,  1997;  Cheng  et al., 
1999).  The NR2B subunit consists of 1456 amino acids with a molecular 
weight of approximately 170-180 kDa.  All of the NR2 subunits have the 
same basic structure as the NR1  subunit (Hollmann & Heinemann,  1994) 
but varying in that they have an  especially large intracellular C-terminal 
domain.  This C-terminal domain, it has been suggested, plays a role as the 
target  for  modulatory  or  accessory  proteins  in  promoting  receptor 
assembly,  sorting  or targeting  and  playing  a  part  in  different  channel 
conformations to  modulate receptor function (Kohr et aI.,  2003; Loftis & 
65 Janowsky, 2003).  The NR2B subunit is modulated by its co-assembly with 
other subunits, alterations in the interaction with associated proteins such as 
PSD-95  and  SAP102,  proteases,  growth  factors,  hormones  and  post-
translational modifications such as phosphorylation.  The phosphorylation 
of tyrosine  residues  can  contribute  to  enhanced  receptor  responses  and 
signal transduction into the neurone (Gurd,  1985; Gurd &  Bissoon,  1997; 
Hisatsune  et  al.,  1999;  Manabe  et  al.,  2000;  Nakazawa  et  al.,  2001). 
Receptor  function  is  also  modulated  by  the  phosphorylation  of serine 
residues  by  protein  kinase  A  (PKA) ,  protein  kinase  C  (PKC),  and 
calmodulin-dependent protein kinase II (CaMKII) (Smart, 1997). 
Ro 25-6981 is an ifenprodil derivative that has high affinity and selectivity 
for the NR2B subunit-containing NMDA receptor but without the affinity 
for  aI-adrenergic  and  serotonergic  receptors  found  with ifenprodil  itself 
(Chenard et al.,  1991;  McCool  &  Lovinger,  1995).  It is  a high affinity, 
selective  (5000-fold  greater  for  the  NR2B  than  the  NR2A  subunit), 
activity-dependent,  voltage-independent  and  non-competitive  NR2B 
subunit-containing NMDA receptor antagonist (Fischer et al.,  1997; Mutel 
et al., 1998; Lynch et al., 2001). 
F. Hoffman-La Roche Pharmaceuticals first described Ro 25-6981 in 1997. 
They used cloned NMDA receptors expressing NR1cINR2A, NRlclNR2B 
and NR1flNR2B subunits to confirm that Ro 25-6981 was selective for the 
NR2B  subunit-containing  receptors. 
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They  also  studied  the electrophysiology of Ro  25-6981  in young cultured rat cortical neurones, 
which express  NR2B  as  the  dominant  NMDA  receptor subunit.  It was 
observed that the  effect of Ro  25-6981  was  dependent upon the relative 
level  of NMDA  receptor  activation.  Ro  25-6981  potently  blocked  the 
current evoked by NMDA lOOIlM but it potentiated the slight responses to 
NMDA 11lM.  Protons (H+)  exert a tonic inhibition of the NMDA receptor 
with an ICso at physiological pH 7.4 by binding at a proton sensor site.  The 
NR2A  and  NR2B  subunit-containing  NMDA  receptors  are  the  most 
sensitive  to  this  effect.  The  proton  sensor's  binding  site  overlaps 
structurally  and  mechanistically  with  the  binding  site  of Ro  25-6981, 
ifenprodil and the endogenous modulators spermine and spermidine (Mott 
et al.,  1998).  The binding stabilises a protonated, agonist-bound state of 
the receptor that has  a low open probability.  This  shifts the pKa of the 
proton  sensor  to  values  that  are  more  alkaline  and  increases  tonic 
inhibition.  However,  the  potentiation  of responses  to  NMDA  by these 
compounds  is  reported  to  be  due  to  an  allosteric  modulation  with  the 
glutamate  and  glycine  binding  sites.  The  binding  of these  compounds 
causes a decrease in NMDA receptor affinity for glycine and an increase in 
affinity for glutamate and NMDA leading to potentiation.  However, while 
ifenprodil and Ro  25-6981  both bind to the N-terminal third of the NR2B 
receptor,  Ro  25-6981  has  a  distinct  binding  site  that  has  greater three-
dimensional  requirements.  Furthermore,  the  binding  of ifenprodil  is 
67 decreased and its IC50  is  increased by rising concentrations of spermidine 
whilst under the same conditions the binding of Ro  25-6981  is unaffected 
and its IC50  decreases (Kew et al.,  1996; Kew et al.,  1998b; Grimwood et 
al., 2000; Lynch et al., 2001; Perin-Dureau et al., 2002).  In addition, Ro 
25-6981  had no  direct effect on the ion channel as  seen with ifenprodii. 
This  clearly  demonstrates  distinct  properties  of action  by Ro  25-6981, 
which  have  not  yet  been  fully  investigated.  This  activity-dependent 
property is  of great significance in therapeutic development as  it predicts 
that NMDA receptors  that  are  pathologically and  continuously  activated 
will be blocked whilst leaving inactive receptors relatively unaffected.  In 
neuroprotective experiments, Ro 25-6981 was found to be very effective in 
protecting  cultured  cortical  neurones  from  excitotoxic  and  ischaemic 
insults (Fischer et al., 1997). 
A further study followed, using autoradiography to investigate the binding 
of Ro  25-6981  to  adult rat brain membranes and tissue sections.  It was 
observed  that  Ro  25-6981  binding  was  similar  to  NR2B  subunit 
distribution  and  dissimilar  to  NR2A  subunit  distribution  (Mutel  et  aI., 
1998). 
More recently,  a study of Ro  25-6981  was  carried out to  characterise its 
NR2B selective pharmacology using human embryonic kidney (HEK) 293 
cells transfected with heterodimers consisting of  NRI a and either wildtype, 
chimeric or mutant NR2B subunits (Lynch et al., 2001) which co-assemble 
68 into  tetrameric  or  pentameric  receptors.  It was  observed  that  specific 
regions  of  the  N-terminal  leucine/isoleucine/valine-binding  protein 
(LIVBP)-like  domain  of  the  NR2B  subunit  protein  modulated  the 
interaction between Ro 25-6981 and the NMDA receptor.  Ro 25-6981 may 
be binding directly to the NR2B subunit or indirectly to the NR1  subunit at 
a site that is modulated by the NR2B subunit in a way that is analogous to 
glycine  binding  to  the NRl  subunit  where  the  NR2  subunit  influences 
glycine affinity (Gallagher et al., 1996; Masuko et al.,  1999; Perin-Dureau 
et a!., 2002).  Whilst Ro 25-6981 is an ifenprodil analogue it has a binding 
site and pharmacology that is distinct from the polyamine site (Lynch et al., 
2001). 
Although there are several NR2B antagonists available, Ro 25-6981  is the 
first compound to be developed that is a highly selective and full antagonist 
at  NR2B  subunit-containing  NMDA  receptors.  Ifenprodil  is  a  partial 
antagonist only inhibiting NR11NR2B  receptors  by 80%  on average  and 
affecting  NR11NR2A!NR2B  receptors  with  little  (Luo  et  al.,  1997)  or 
intermediate effect  (Tovar &  Westbrook,  1999).  Also,  ifenprodi1  is  not 
very  selective for the NR2B  subunit (400-fold,  recombinant NR11NR2B 
compared  to  NR1INR2A)  and  also  blocks  aI-adrenergic,  5HT  lA,  5HT  2, 
5HT3 and sigma receptors and N, P and Q type calcium channels (Chenard 
et al.,  1991; McCool &  Lovinger, 1995). Interestingly, Pfizer has recently 
developed an NR2B subunit-selective antagonist CP-10 1, 606, which has a 
69 very low affinity for the NR11NR2A1NR2B  synaptic receptors but a high 
affinity for the purely extrasynaptic NR11NR2B population (Chenard et al., 
1995;  Tovar  &  Westbrook,  1999).  It would  be  of particular interest  to 
repeat this study using CP-101, 606 to  investigate further the contribution 
of synaptic versus extrasynaptic receptor populations (Hardingham et al., 
2002).  There  have  been  several  recent  reports  demonstrating  that  the 
different subunit-containing NMDA receptors  and the locus of activation 
has a great effect on determining the direction of synaptic plasticity (Liu et 
al., 2004; Massey et al.,  2004;  Rusakov et al.,  2004;  Wong  et al.,  2004; 
Mallon et al.,  2005)  and the phosphorylation of CREB  (cAMP response 
element  binding  protein)  leading  to  BDNF  expression  and  pro-survival 
pathways (Hardingham et al., 2002; Riccio & Ginty, 2002). 
Novartis  Pharmaceuticals  have  recently  developed  an  NR2A  subunit-
containing  NMDA  receptor  antagonist  (R)-[(S)-l-(  4-bromo-phenyl)-
ethyl amino  ]-(2,3-dioxo-1 ,2,3 ,4-tetrahydroquinoxalin-5-yl)-methyl]-
phosphonic  acid  (PEAQX,  also  known  as  NVP-AAM077,  appendix  2). 
PEAQX is a water-soluble 5-methyl-quinoxalinedione with a high affinity 
for  the  glutamate-binding  site  of the  NMDA  receptor  ([3H]-CGP39653 
binding  assay:  ICso  =  llnM).  At  lOflM PEAQX showed  no  additional 
activity in a  series  of 68  radio ligand binding  assays  for  CNS  receptors. 
PEAQX has  126-fold  selectivity  for  the NMDA NR1A1NR2A  over the 
NR1A1NR2B  receptors expressed in Xenopus oocytes (IC50  =  14nM and 
70 1800nM respectively).  Experiments  on  embryonic  cortical  cells  and on 
neocortical  slices  have  confirmed  these  results  with  native  receptors. 
Cultured embryonic  cortical  cells  express  NR2A subunits  at  a very  low 
level, resulting in a low potency of PEAQX (ICso  =  1  ~M).  In adult slices 
where NR2A subunits are predominantly expressed the effect of  PEAQX is 
stronger  (IC50  =  68nM)  than  in  cultured  embryonic  cortical  cells  that 
express  NR2A  at  very  low  levels  (undetectable)  (ICso  =  1  ~M). 
Furthermore,  in vivo  PEAQX  was  found  to  be  a  potent  anticonvulsant 
following intravenous dosing with few of the side effects associated with 
non-selective or NR2B selective antagonists (Auberson et al., 2002). 
Although these compounds have been examined on recombinant receptors 
and  immature  cultures,  which  are  systems  that  over-express  the  NR2B 
subunit-containing NMDA receptors, this study has used these compounds 
to examine the role of  NR2 subunits in an intact neuronal network in which 
adult heteromeric NMDA receptors are involved in synaptic transmission 
and  plasticity.  Of great  importance  in  this  study  was  the  use of adult 
animals that are 7-8 weeks old because they are past the 3
rd postnatal-week 
threshold for the maturation ofNMDA receptor subunit expression (where 
NR2A  subunits  are  the  last  to  reach  their  mature  levels)  and  the  4th 
postnatal-week threshold during which the basal levels of  receptor tyrosine 
phosphorylation are attained (Cudmore & Gurd, 1991; Tovar & Westbrook, 
1999). 
71 Results 
NMDA 
We  started  this  study  usmg  lO-minute  applications  of NMDA,  which 
reversibly  depressed the  slope  of the fEPSP.  The  depression  of fEPSP 
slope  being  a  reflection  of  changes  in  membrane  conductance  and 
depolarisation of  the neurones.  This leads to the depolarisation block of  the 
CAl  neurones  recorded  from  and  the  subsequent blockade of excitatory 
transmission.  The concentration-response relationship was very steep, with 
l/-lM having had no effect, 4/-lM producing a response that was discernible 
but  not  statistically  significant,  while  7.5/-lM  produced  a  depression  to 
69.36±16.33%,  lO/-lM  produced a  depression to  l5.l8±4.43% (Figure  5) 
and 20/-lM producing a depression to -1.05±1.61 % of fEPSP  slope (Figure 
4).  Furthermore,  investigation of changes  to  the  paired-pulse paradigm 
during  the  depression  elicited  by  NMDA  lO/-lM  found  a  significant 
decrease of  paired-pulse inhibition, and increase of  paired-pulse facilitation 
at  all  interstimulus  intervals  (lOms  p<O.OOl,  20ms,  p<O.Ol  and  50ms 
p<O.Ol, n=5) (Figure 6 and 7). 
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Figure  4.  Concentration  curve  of the  inhibitory effect of NMDA  upon  fEPSP 
slope. 
Graph showing the non-cumulative concentration-response curve of depression 
of fEPSP slope in  response to  10-minute applications of NMDA concentrations 
of  1~M, 4~M, 7.5~M,  10~M and  20~M, n=4,  13,  4,  8  and  4  respectively.  A 
concentration of 8.6~M is predicted to cause a 50% depression of fEPSP slope. 
Each point shows the mean±s.e.m. 
73 II NMDA 10flM 
Figure 5.  Effect of NMDA 10flM on fEPSP slope. 
Plot showing the effect of a 10-minute application of 10IJM  NMDA, which elicits 
a depression in the slope to  15.18±4.43% of fEPSP (p<O.001).  Points (c),  (1) 
and  (2)  indicate the  timing  of the  paired-pulse tests summarised  in  Figure  6. 
Each point shows the mean±s.e.m. for n=8 experiments. 
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Figure 6.  Effect of NMDA 10!-lM on paired-pulse interactions. 
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Graph  showing  the  paired-pulse  interactions  of fEPSP  slope  at  interstimulus 
intervals of 10ms,  20ms and  50ms during the  baseline control  responses (c), 
10!-lM  NMDA  (1)  and  the washout  period  (2)  (10ms  p<O.001,  20ms  p<O.01, 
50ms  p<O.01,  n=5,  1  compared  to  2  and  c)(see  plot  in  figure  5  for 
corresponding times points and example records in figure 7).  Each point shows 
the mean±s.e.m. for n=5 experiments. 
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Figure  7.  Example  records  of  paired-pulse  interactions  during  baseline 
recording and under the influence of 10IJM NMDA. 
Showing paired-pulse interactions recorded during baseline recording: (a) 10ms 
(b) 20ms and  (c) 50ms and during the depression caused  by NMDA 10~M: (d) 
10ms (e) 20ms and (f) 50ms (points relate to same pOints in figures 5 and 6). 
76 Ro 25-6981 
The large depressions  of fEPSP  slope elicited by applications of NMDA 
were  caused  by  the  activation  of native  heteromeric  NMDA  receptors 
containing a combination ofNR1, NR2A, NR2B and NR2D subunits.  This 
study  investigated  the  contribution  of NR2B  subunit-containing  NMDA 
receptors using the NR2B antagonist Ro 25-6981.  A concentration of  3 ~ 
Ro  25-6981  was  chosen  as  it  has  previously  been  shown  to  block 
selectively  the  NR2B  component of the  NMDA  excitatory  postsynaptic 
current (NMDAEPSc)  in 3-4  week old rats  and not the NR2A component 
(Liu  et al.,  2004).  Repeated  applications  of NMDA  10J.lM  caused  two 
similar  reversible  depressions  of fEPSP  slope  to  16.06±9.16%  then  to 
12.85±7.85% (p<0.001, n=4).  The co-application of3J.lM Ro 25-6981  had 
no immediate effect upon this depression, which again reversibly depressed 
the fEPSP  slope to  8.96±2.77% (p<0.001,  n=4).  However, the  next  10-
minute application of NMDA started 5 minutes  after the  end of the  20-
minute application of Ro 25-6981  3  J.lM totally abolished the fEPSP, which 
then  slowly  and  partially  recovered  to  37.56±7.26%  of the  baseline 
responses  and  remained depressed  for  at  least the  100  minutes  recorded 
(p<0.001,  n=4)  (figure  8  and  9).  Attempts  to  recover the  response  by 
increasing  afferent  stimulation  or  by  HFS  stimulation,  which  normally 
induces LTP (responses not shown), were unsuccessful.  This observation 
is  consistent with a terminal  excitotoxic  insult to  the  neurones  recorded 
77 from and inconsistent with the induction of  LTD as witnessed by the failure 
to reverse it with an L  TP inducing protocol or by increasing the stimulation 
of  the presynaptic afferents (Schurr et aI.,  1995). 
Following the intensity of  the response to  lOI-LM NMDA, a concentration of 
NMDA 4I-LM  was  used,  a  concentration that produced a  smaller control 
depression of baseline fEPSP  slope (figure 10).  This would be less likely 
to  result  in  an  excitotoxic  insult  after  the  application  of Ro  25-6981. 
Applications of NMDA 4I-LM  caused two small yet discernible depressions 
of fEPSP slope that were not statistically significant (i and ii).  Again the 
co-application of Ro  25-6981  3I-LM with a third application of  NMDA (iii) 
had no immediate effect but a fourth application, during the washout phase 
of Ro 25-6981  (iv), showed a significant enhancement of the depression of 
fEPSP  slope.  The fifth application of NMDA (v)  caused an even greater 
depression  of fEPSP  slope  that  was  matched  in  size  by  the  sixth  and 
seventh  (vi  and  vii)  applications  with  no  washout  of the  effect  being 
observed up to  100 minutes after Ro  25-6981  had been removed from the 
perfusate (significant depressions of fEPSP  slope to  (iv) 40.94±4.56%, (v) 
19.78±6.7%,  (vi)  19.28±10.74%  and  (vii)  13.23±4.18%  (all  p<O.OOl 
compared to  the second NMDA 4I-LM  induced depression, n=4)).  Lastly, 
the application of the NR2A subunit-selective antagonist PEAQX O.lI-LM 
during the eighth and final  application of NMDA 4I-LM  (viii) completely 
78 blocked any depression of fEPSP slope i.e. both the initial control NMDA 
4~M  portion and the enhanced portion induced by Ro 25-6981 (figure 10). 
This  study also  investigated the effect of Ro  25-6981  upon responses to 
low concentrations of NMDA using  intracellular recording techniques to 
investigate  the  effect  solely  on  the  excitability  of  the  postsynaptic 
pyramidal  cell  (Appendix  1).  A  similar  enhancement  of responses  to 
NMDA was induced over the same time course as  seen with extracellular 
recordings.  This suggests a predominantly postsynaptic site of action for 
these effects. 
79 Cl) 
c. 
~  120 
en 
c..  100  en 
c.. 
!i!:!  80 
Cl) 
s::::  .- -
60 
40 
20 
o 
i 
o 
II 
NMDA 10~M 
Ro 25-6981  3~M 
I  I 
2 
i  i  i  i 
50  100  150  200 
time (mins) 
Figure 8.  Repeated 10-minute applications of 10j..lM NMDA and the effect of 
3j..1M  Ro 25-6981. 
Plot showing the co-application of 3j..1M  Ro 25-6981  had no immediate effect 
upon the response to 10j..lM NMDA, whereas the next application of NMDA was 
potentiated to the extent that the fEPSP was initially abolished and then shows 
only partial recovery (p<O.001, n=4).  Each point shows the mean±s.e.m. for 
n=4 experiments. 
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Figure 9.  Representative fEPSPs showing excitotoxic damage. 
Recordings  of  fEPSPs  showing  the  irrecoverable  depression  of  baseline 
responses  caused  by  the  excitotoxic  insult of NMDA  10l-lM  and  Ro  25-6981 
31-lM  (2)  compared with  baseline responses (1).  Numbered traces correspond 
to the time course in figure 8. 
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Figure 10.  Effect of Ro 25-6981  and NMDA 4~M  on fEPSP slope. 
Plot showing the effect of repeated 10-minute applications of 4j..1M  NMDA, which 
produced  a small depression of the fEPSP slope.  The application of 3j..1M  Ro 
25-6981  had no immediate effect upon this, but subsequent applications of  4j..1M 
NMDA  show  the  development  of potentiation  in  the  fEPSP  slope  (p<O.001, 
n=4).  The  co-application  of PEAQX  at  O.1j..1M  completely  blocked  the  final 
potentiated  response to  NMDA.  Each  point shows  the  mean±s.e.m. for n=4 
experiments 
82 NMDA receptor antagonism 
A surprising feature of  these experiments was that the effect of  Ro 25-6981 
developed slowly, required at least 20 minutes to elicit a clearly significant 
decrease  in response  size and  the effect gradually  continued to  develop 
during the washout phase.  In addition this  effect,  once fully  developed, 
was long lasting, with no  attenuation of the depressed response size being 
observed  for  up  to  100  minutes  post-washout.  The  continuous  bath-
application of NMDA 4f.!M was employed in order to  observe better how 
the effect of Ro 25-6981  developed.  As shown in figure 11, NMDA 4f.!M 
initially produced a small,  stable depression of baseline fEPSP  slope, the 
co-perfusion  of Ro  25-6981  3f.!M  produced  a  slight  recovery  of the 
responses  but  near  the  end  of the  20-minute  perfusion  the  depression 
gradually develops.  As Ro 25-6981  started to washout the depression had 
reached 70.42±12.18% of baseline fEPSP slope.  In spite of the absence of 
perfusing Ro 25-6981 the depression continued to gradually develop.  The 
depression  stabilised  30  minutes  after  the  washout  of Ro  25-6981  at 
33.84±0.32% (p<0.001; n=5) of baseline fEPSP slope.  The application of 
the  competitive,  non-selective  NMDA receptor antagonist  2-AP5  50llM 
reversed  the  depression  to  near-baseline  responses.  However,  after the 
washout of 2-AP5 the depression reasserted itself within approximately 18 
minutes  (p<O.OOl;  n=5).  At  the  end  of the  experiment  and  with  the 
washout of NMDA, the fEPSP  slope returned to  a level not significantly 
83 different from the initial baseline responses (Figure  11).  An examination 
of paired-pulse interactions during this experiment found that paired-pulse 
ratios  were  enhanced  during  the  Ro  2S-6981-mediated  enhancement  of 
NMDA 4f.lM (p<O.OOI, n=S at all interstimulus intervals) but were returned 
to  baseline responses  during the reversal of this depression caused by 2-
APS (figure 12). 
Repeating the same protocol using a slightly higher level of NMDA at a 
concentration  of  7  .S f.lM  (figure  13)  produced  a  modest  and  stable 
depression of fEPSP  slope to  64.6±10.4% (not significant, n=4).  The co-
application of  Ro 2S-698l 3  f.lM caused an enhancement of this depression, 
which  started  during  Ro  2S-6981  co-perfusion  and  continued  during 
washout until it reached a stable plateau of -0.16±0.24% (p<O.OI;  n=4) of 
baseline fEPSP  slope within approximately  18  minutes of the depression 
beginning.  The  application  of the  competitive,  non-selective  NMDA 
receptor antagonist 2-APS  SOf.lM  significantly reversed the depression of 
fEPSP slope back to the level previously seen with NMDA alone (p<O.OI; 
n=4).  Again, during the washout of 2-APS the depression reasserted itself 
within approximately  18  minutes to  O.80±O.29%  (p<O.OOI;  n=4).  At the 
end of the  experiment  and  with the washout of the NMDA,  the  fEPSP 
returned to  a level not significantly different from  the baseline responses 
although it was apparent that the level and duration ofNMDA agonism had 
had a deleterious effect upon the response size.  The rate of onset of effect 
84 was quicker with NMDA 7.5!J.M (18  minutes) than with NMDA 4!J.M (30 
minutes)  perhaps  reflecting  the increased rate  of binding  with  increased 
concentration of NMDA as  previously reported with glutamate (Mutel et 
al., 1998) and with ifenprodil (Grimwood et al., 2000).  Figure 14 shows a 
concentration-response curve of the  effect of NMDA concentrations and 
the degree to which they are potentiated to  under the influence of Ro  25-
6981  3  !J.M.  This  shows  a shift to  the left of the NMDA concentration-
response  curve  after the  application  of Ro  25-6981.  The  concentration 
required to  elicit a 50% depression of fEPSP  slope changed from  1.7!-lM 
with NMDA alone to 8.6!-lM under the influence ofRo 25-6981. 
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Figure  11.  Effect of Ro  25-6981  on the continuous application of NMDA 4IJM 
and its reversal by 2-AP5. 
4IJM  NMDA  caused  a  slight  depression  in  the  fEPSP  slope  (c).  The  co-
application of 3IJM  Ro 25-6981  increased this response; the increase occurred 
slowly during  Ro  25-6981  washout  into  a  stable  plateau,  (1)  fEPSP  slope  of 
33.84±O.32%  (p<O.001;  n=5)  compared  with  the  baseline.  The  competitive 
NMDA receptor antagonist 2-AP5 (50IJM) reversed the depression (2) (p<O.001; 
n=5).  During  the  washout of 2-AP5,  the  potentiated  response  to  NMDA  re-
asserted itself (p<O.001; n=5), but recovered to  baseline values upon removing 
the NMDA.  Each point shows the mean±s.e.m. for n=5 experiments. 
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Figure 12.  Effect of NMDA 4J..lM  and Ro 25-6981  on paired-pulse interactions. 
This  graph  summarises  paired-pulse  interactions  at interstimulus  intervals  of 
10 ms,  20 ms  and  50 ms,  corresponding to points (c),  (1) and  (2)  in  figure  11. 
The results demonstrate a significant enhancement of paired-pulse interactions 
during  the  trough  of the  depression  caused  by  Ro  25-6981  and  NMDA  (1) 
(10 ms p<0.001, 20 ms p<0.001, 50 ms p<0.001, n=5) compared with baseline 
responses (c).  These changes were reversed by 2-AP5 (2).  Each point shows 
the mean±s.e.m. for n=5 experiments 
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Figure 13.  Effect of Ro 25-6981  on the continuous application of NMDA 7.51JM 
and its reversal by 2-AP5. 
7.51JM  NMDA  caused  a  modest  (64.6±10.4%;  n.s.  n=4)  depression  of the 
fEPSP slope.  The co-application of 3IJM  Ro  25-6981  increased this response; 
the increase occurred slowly during Ro  25-6981  washout into a stable plateau 
fEPSP slope of -O.16±O.24%  (p<O.01;  n=4) compared  with the  baseline.  The 
competitive NMDA receptor antagonist 2-AP5 (50IJM)  reversed the depression 
(p<O.01;  n=4).  During  the  washout  of 2-AP5,  the  potentiated  response  to 
NMDA re-asserted itself (p<O.001;  n=4), but recovered to baseline values upon 
removing the NMDA.  Each point shows the mean±s.e.m. for n=4 experiments. 
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Figure  14.  The  concentration-response  curve  of  NMDA  alone  and  after 
Ro 25-6981. 
Graph summarising the concentration-response curves for responses to NMDA 
in  the  presence  and  absence  of 3IJM  Ro  25-6981,  and  showing  the  marked 
leftward  shift  produced  by the  combination.  NMDA alone  (1,  4,  7.5,  10  and 
20/-lM)  and  Ro  25-6981  potentiated  responses  to  NMDA (0.1,  1,  4,  7.5  and 
10/-lM).  The concentration eliciting a 50% depression of fEPSP slope changes 
from 8.61JM for NMDA alone to 1.71JM under the influence of Ro 25-6981.  Each 
point shows the mean±s.e.m. 
89 2-APS  is  a  competitive  antagonist  at  the  NMDA  receptor's  glutamate 
binding site, in order to test that this was not a compounding factor in the 
blockade of the effect of Ro  2S-698l  the non-competitive,  open channel 
blocker dizocilpine (MK 801) was used to  antagonise the NMDA receptor 
during the co-application of Ro  2S-698l  and NMDA.  The application of 
NMDA 4~M  caused a small,  stable depression of fEPSP  slope that was 
reversed by the application of MK 801  10~M to  baseline response size. 
The perfusion of Ro 2S-6981  3  ~M  had no effect upon the fEPSP slope and 
during  the  washout  of MK 801  the  response  size  remained  at  baseline 
levels (figure IS).  However, the non-competitive antagonism provided by 
MK 801  was not  washed out  of the  slice  over the time-period recorded 
from and this is a likely reason for the lack of  any depression observed. 
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Figure 15.  Effect of  4~M  NMDA and  Ro 25-6981  in the presence of MK 801  on 
fEPSP slope. 
Plot  showing  the  effect  of 1  O~M MK  801  applied  throughout the  combined 
application  of 4~M NMDA and  3~M Ro  25-6981.  An  initial,  small  depression 
(approximately 5%) produced  by NMDA was  blocked  by  10~M MK 801.  This 
prevents the development of a potentiated response to NMDA plus Ro 25-6981 
even after the washout of MK 801.  Each point is the mean±s.e.m. for n=3. 
91 Having previously demonstrated that the Ro 25-6981-mediated potentiation 
of  responses to NMDA was transiently reversible by applying 2-AP5  50~M 
this  study  investigated whether,  by applying  this  competitive  antagonist 
before,  during  and  after Ro  25-6981,  the  induction of the  depression of 
fEPSP slope could be prevented.  As shown in figure 16 the application of 
NMDA 4~M  produced a slight, stable depression of the fEPSP  slope that 
was reversed to  above the baseline levels by the subsequent application of 
2-AP5.  The co-application ofRo 25-6981  3~M  had no further effect upon 
the  fEPSP  response,  2-AP5  preventing the depression  normally  elicited. 
However,  as  2-AP5  was  washed  out  the  depression  of fEPSP  slope 
developed  rapidly  to  14.06±5.09%  of baseline  fEPSP  slope  (p=0.0178, 
n=4) within approximately 20 minutes of  it starting to reduce.  The gradient 
of the development of this depression was similar to that seen with 2-AP5 
washout  in  figure  11  and  13;  i.e.  a  depression  that  is  linear  and  rate-
dependent upon the washout of 2-AP5.  The gradient was dissimilar to the 
Ro 25-69811NMDA 4~  gradient of  figure  11, which is rate-dependent on 
the  effect initiated by  Ro  25-6981,  which is  a slower developing  effect 
(approximately 30  minutes).  Therefore,  the effect of Ro  25-6981  would 
seem to have already been realized during 2-AP5 co-perfusion suggesting 
that it does not require NMDA receptor activation.  The difference in these 
gradients may be explained by the binding of Ro  25-6981  having already 
taken place during 2-AP5 perfusion; 2-AP5 was able to suppress the NR2A 
92 activation-dependent expression of its effect but not the binding of Ro 25-
6981 to its unique site on the NR2B subunit and the mechanism it puts into 
effect to produce the enhanced depression of  fEPSP slope. 
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Figure 16.  Effect of 2-AP5 continuously bath-applied  during the application of 
4jJM NMDA and Ro 25-6981 on fEPSP slope. 
A  plot  showing  the  effect  of 50jJM  2-AP5  applied  throughout  the  combined 
application  of 4jJM  NMDA and  3jJM  Ro  25-6981.  An  initial,  small  depression 
(approximately 5%) produced by NMDA was blocked by 50jJM  2-AP5.  Despite 
this, the application of 2-AP5 did  not prevent the development of a potentiated 
response to  NMDA plus Ro  25-6981, which  appeared  after washout of the 2-
AP5  and  persisted  until  the  NMDA  was  removed.  Each  point  is  the 
mean±s.e.m. for n=4 experiments. 
94 PEAQX 
The bath application of NMDA in the adult rat hippocampus will activate 
NMDA receptors containing NR2A, NR2B and NR2D subunits.  In view of 
the potentiating activity produced when the NR2B element to the action of 
NMDA was blocked by Ro 25-6981, the putative NR2A subunit antagonist 
PEAQX was used to investigate the residual response to NMDA.  NMDA 
4f.lM was continuously bath-applied producing a small, stable depression of 
fEPSP  slope  (figure  17).  The  co-perfusion  of  3f.lM  Ro  25-6981 
transformed this  into  a large depression to  31.90±1.0 1  %  of the baseline 
fEPSP slope (p<0.05, n=3) that developed over approximately 30 minutes. 
It was then reversed by the application of PEAQX 0.1 f.lM back to baseline 
fEPSP  responses.  The rate of washout of PEAQX was initially rapid but 
after 8 minutes, it slowed to  such an extent that it still did not completely 
washout for at least 2 hours.  These experiments were therefore concluded 
before the depression might be observed to fully re-establish. 
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Figure 17.  Effect of NMDA, Ro 25-6981  and PEAQX on fEPSP slope. 
This plot shows the interaction of NMDA, Ro 25-6981  and PEAQX.  4iJM NMDA 
produces  a  small,  stable  depression,  but  co-perfusion  of  3iJM  Ro  25-6981 
transforms  this  into  a  large  depression  that  reaches  31.90±1.01 %  of the 
baseline fEPSP slope (p<0.05, n=3).  This depression was reversed by 0.1  iJM 
PEAQX.  The partial washout of PEAQX stabilised after 8 minutes but does not 
completely  wash  out for at  least two  hours.  The  experiment was  therefore 
terminated  before the  depression was fully  re-established.  Each  point is  the 
mean±s.e.m. for n=3 experiments. 
96 Protein phosphorylation 
The phosphorylation state of the NMDA receptor and many other cellular 
proteins determines their activity and function (Smart,  1997).  This study 
next  investigated  the  involvement  of  protein  kinases  and  protein 
phosphatases on the Ro 25-6981 effect. 
Staurosporine (STA) is a broad-spectrum protein kinase inhibitor, enzymes 
inhibited  include:  PKC  (ICso=3nM),  PKA  (ICso=7nM),  tyrosine  protein 
kinase  (ICso=6nM)  and  CaMKII  (ICso=20nM)  (Tamaoki  et  al.,  1986; 
Ruegg &  Burgess, 1989; Yanagihara et al.,  1991).  As shown in figure  18 
the initial 10-minute application ofNMDA 4~M  caused a small depression 
of the  fEPSP  slope,  staurosporine  lOOnM  was  continuously bath-applied 
and had no effect upon baseline fEPSP slope or the depression produced by 
a further 10-minute application ofNMDA 4~M. The application ofRo 25-
6981  3~M  and the subsequent application ofNMDA produced a significant 
depression of fEPSP  slope to  17.66±lO.83% (p<O.Ol,  n=3)  compared to 
baseline  responses.  After washout,  a  final  application  of NMDA  4~M 
produced  another  significant  depression  of fEPSP  slope  to  1.77±O.87% 
(p<O.OOl,  n=3)  compared to  baseline responses  (Figure  18).  Therefore, 
staurosporine  was  unable  to  prevent  the  potentiation  of responses  to 
NMDA 4~M  by Ro 25-6981. 
97 The  first  phosphatase  inhibitor  investigated  was  okadaic  acid  (OA),  a 
potent inhibitor of  the serine/threonine protein phosphatases types 1 and 2A 
(PP1  and PP2A) (Bia10jan & Takai, 1988).  The continuous application of 
NMDA  4~M elicited  a  small,  stable  depression  of fEPSP  slope.  The 
addition of okadaic acid before, during and after the co-application of Ro 
25-6981  3  ~M was  unable  to  prevent  the  development  of a  significant 
depression  of  the  fEPSP  slope  to  1.56±0.3l %  (p<O.OOl,  n=4). 
Interestingly, upon washout the  fEPSP  slope recovered to  an  average of 
156.5±14.62% (p<0.05,  n=4)  of baseline responses,  a significant LTP of 
responses that was  stable (figure  19).  This  LTP-inducing effect was not 
investigated further at this time. 
Cyc1osporin  A  (CyA) ,  a  widely  used  serine/threonine  Ca
2+/calmodulin-
dependent  phosphatase  2B  (calcineurin)  inhibitor,  was  used  next.  The 
continuous bath-application ofNMDA 4~M  again produced a slight, stable 
depression of fEPSP slope.  The application of 1  ~M  cyc1osporin A had no 
significant effect on the baseline fEPSP slope but it was able to prevent the 
anticipated  enhancement  of the  NMDA  4~M-mediated depression  of 
fEPSP  slope  previously  seen  after  the  application  of Ro  25-6981  3  ~M 
(figure 20).  Interestingly the baseline fEPSP returned to values that were 
significantly potentiated (132±0.81 %,  p<0.05,  n=4) compared to  baseline 
responses.  The application of cyc1osporin A prevented the depression of 
fEPSP  slope seen with both the control group and the experiments using 
98 okadaic  acid  and  staurosporine,  which  were  unable  to  inhibit  the 
development  of the  depression.  Interestingly,  the  magnitude  of the 
depression of fEPSP slope was significantly greater than the control group 
for both okadaic acid and staurosporine (figure 21). 
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Figure 18.  Action of staurosporine upon the effect of the co-application of 4~M 
NMDA and Ro 25-6981  on fEPSP slope. 
Plot showing repeated applications of NMDA 4~M  produced a small depression 
of  fEPSP  slope  that  was  not  prevented  by  the  co-application  of  100nM 
staurosporine.  The co-application of staurosporine was also not able to prevent 
the enhancement of NMDA responses by Ro  25-6981  3~M which  produced  a 
significant depression  of the  fEPSP  slope  to  17.66±10.83% (p<O.01).  Each 
point shows the mean±s.e.m. for n=3 experiments. 
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Figure 19.  Action of okadaic acid upon the effect of the co-application of 4IJM 
NMDA and Ro 25-6981  on fEPSP slope. 
Plot showing  that the  continuous application of NMDA 4IJM  produced  a small 
depression of fEPSP slope.  The co-application of staurosporine before, during 
and  after  Ro  25-6981  was  not  able  to  prevent  the  enhancement  of NMDA 
responses by Ro  25-6981  3IJM  which produced a significant depression of the 
fEPSP  slope  to  1.56±O.31 %  (p<O.001,  n=4).  Each  point  shows  the 
mean±s.e.m. for n=4 experiments. 
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Figure  20.  Prevention  by cyclosporin  A  of the effect of the co-application  of 
4\-1M  NMDA and Ro 25-6981  on fEPSP slope. 
Plot  showing  the  effect  of  1  \-1M  cyclosporin  A  (CyA)  upon  the  Ro  25-6981 
potentiation of NMDA responses.  4\-1M  NMDA produced a slight, non-significant 
depression of fEPSP slope; the application of CyA had  no  significant effect on 
this  but  prevented  the enhancement of the  NMDA  response  by  3\-1M  Ro  25-
6981.  Each point shows the mean±s.e.m. for n=4 experiments 
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Figure 21.  Column bar graph summary of phosphorylation modulators. 
This histogram summarises the depression caused by the co-application of 4!JM 
NMDA and 3!JM  Ro 2S-6981  under control conditions (figure 11, n=4) and with 
the co-perfusion  of 1!JM  cyclosporin  A  (CyA)  (figure  20,  n=4),  SOnM  okadaic 
acid  (OA)  (figure  19,  n=4)  and  100nM  staurosporine  (STA)  (figure  18,  n=3). 
Cyclosporin A prevented the depression of the fEPSP slope induced by NMDA 
in  the  control  group  (p<0.001).  However,  okadaic  acid  and  staurosporine 
increased the magnitude of the depression (both p<0.01). 
103 Protein synthesis 
In view of the latency of onset, the long-lasting effect of Ro 25-6981, and 
the involvement of protein phosphorylation the question arose of whether 
any permanent change was required and induced of new protein synthesis. 
To  investigate  this  possibility  anisomycin,  a  widely  used  reversible 
translation  inhibitor  was  used  (GroHman,  1967).  The  application  of 
NMDA  4~M  produced a  small,  stable  depression of fEPSP  slope.  The 
continuous application of anisomycin 30~M  had no significant effect upon 
the fEPSP  slope nor was  it able to  interfere with the subsequent NMDA 
and Ro  25-6981-mediated depression  of fEPSP  slope to  10.65±O.3628% 
(p=O.0128, n=4)(figure 22). 
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Figure 22.  Effect of anisomycin on  the Ro  25-6981/NMDA effect upon fEPSP 
slope. 
Plot showing that 30jJM  anisomycin was unable to prevent the development of 
the Ro  25-6981-mediated enhancement of NMDA responses (p=O.0128,  n=4). 
Each point shows the mean±s.e.m. for n=4 experiments. 
105 Discussion 
Applications of NMDA produced a concentration dependent depression of 
evoked fEPSP  slope that was associated with an  enhancement of paired-
pulse ratios at all interstimulus intervals.  The fEPSP under normal 0.05Hz 
stimulation is predominantly a reflection of the fast kinetics of the AMP  A 
receptors which underlie this recording, with fast  rise times (10-90% rise 
time  of ~400!ls) and  fast  decay  time  constant  (~1.3ms).  The  NMDA 
component, in contrast, has slow kinetics with a slow rise time (~9ms) and 
a slow mean decay time constant  (~52ms) (Gibb  et al.,  1994).  Schaffer 
collateral  inputs  onto  CAl  neurones  elicit  fEPSPs  where  the  NMDA 
receptors  contribute  only  very  a  small  component  (~3%) (Arrigoni  & 
Greene,  2004),  principally  as  a  result  of the  magnesium  block  of the 
channel  at  resting  membrane  potentials.  At  these  negative  membrane 
potentials,  the  magnesium  ion  blocks  the  ion  channel  in  a  voltage-
dependent  non-competitive  manner.  The  depolarisation  induced  by  a 
single fEPSP is not sufficient to overcome the threshold leading to NMDA 
receptor  activation  because  the  membrane  potential  does  not  reach  a 
sufficient level to expel the magnesium ion.  However, repetitive activation 
of the synapse such as that seen in HFS  and LFS  stimulation protocols to 
induce  LTP  and  LTD  produces  a  non-linear  summating  effect  which 
overcomes  this  threshold  and  leads  to  the  activation  of the  NMDA 
receptors.  It  is  apparent  from  current-voltage plots  for  NMDA-induced 
106 conductances  that  even  at -90m  V,  although the  NMDA current  is  very 
small  it  is  never entirely prevented by magnesium block (Mayer  et a/., 
1984;  Nowak  et at.,  1984).  The  bath  application  of NMDA  receptor 
agonists will lead to  the activation of synaptic and extrasynaptic NMDA 
receptors  which  will  result  in  large  conductance  through  their  SOpS 
channels  over longer time periods than that seen with AMP  A receptors, 
producing a regenerative feedback that leads to  the unblocking of NMDA 
receptors  and  their  activation.  This  conductance  then  leads  to  the 
depolarisation of  the cells recorded from and the subsequent depolarisation 
block of  excitatory synaptic transmission, manifested as a loss of  the fEPSP 
slope.  The washout of NMDA agonist allows the neurones to rebuild the 
ionic  gradients  that  underlie  the  membrane  potential  and  the  fEPSP 
response recovers.  The application of NMDA agonists which leads to this 
depolarisation  will  also  lead  to  the  activation  of GABAA  and  GABAB 
receptors  responsible for  fast  and  slow components of feed-forward  and 
feedback inhibitory transmission.  Although this study did not address the 
contribution of these  effects  on the  changes  in the depression  of fEPSP 
slope  or on  paired-pulse  interactions  previous  investigations  found  that 
GABA, bath-applied to the hippocampal slice, elicited no inhibition of the 
fEPSP slope or altered the paired-pulse interactions in concentrations up to 
lmM (unpublished observations).  This suggested that the contribution of 
additional GABA release in this preparation is limited or already saturated 
by concentrations of  GABA released in response to afferent stimulation. 
107 Ro  25-6981  has  been  described  as  a  selective  antagonist  at  the  NR2B 
subunit of the NMDA receptor.  However, the previous work was carried 
out deliberately on immature tissue or cloned receptors overexpressing the 
NR2B subunit and not in adult tissues expressing mature NMDA receptors. 
When tested on the intrinsic neuronal circuitry of the adult hippocampal 
slice Ro 25-6981 unexpectedly potentiated NMDA receptor activation at all 
concentrations  of NMDA  tested  and  showed  no  inhibition  of NMDA 
responses.  The increased depression of  fEPSP slope was generated through 
NR2A subunit-containing receptors,  since the potentiated response could 
be  blocked  selectively  by  PEAQX.  Furthermore,  this  enhancement 
appeared to  have  a presynaptic component,  since the paired-pulse ratios 
were  significantly  enhanced  during  potentiated  responses  to  NMDA  at 
concentrations  that  previously  showed  no  such  change  from  baseline 
responses.  It is widely recognised that a loss of  paired-pulse inhibition and 
an increase of paired-pulse facilitation represents a presynaptic action of 
the test agents.  Although it does not follow that postsynaptic effects cannot 
influence the appearance of PPD and PPF in field recordings (Seabrook et 
a!.,  1999).  Additionally,  evidence  from  intracellular  recordings  of the 
enhancement  of NMDA  responses  by  Ro  25-6981  suggests  that  this 
phenomenon  has  a  predominantly  postsynaptic  locus.  The presynaptic 
element of responses to NMDA suggested in this study may be mediated 
via NR2A or NR2A1NR2B subunit-containing receptors.  This is consistent 
with  evidence  for the  existence  of presynaptic  NMDA receptors,  which 
108 may be responsible for changes in presynaptic release probability and the 
changes in paired-pulse interactions described here. 
The most parsimonious explanation of the present results would be that the 
NR2B subunits exert a tonic inhibitory restraint on the activation of NR2A 
subunit-containing NMDA receptors.  Blockade of  the NR2B subunits then 
results  in  disinhibition  of NR2A  subunit-containing  receptors,  which 
become the primary effectors of the increased response to  NMDA.  This 
would explain both the potentiating effect of Ro 25-6981  and the blockade 
of the potentiated responses by PEAQX.  It is  not possible to  conclude 
from  the  present  data  whether this  inhibitory  subunit  interaction  occurs 
between subunits within single heterotrimeric NR11NR2A1NR2B receptors 
or  between  discrete  heterodimeric  receptors  containing  exclusively 
NR11NR2A and NR1INR2B subunits.  Additionally, the interaction may be 
between receptor populations located at different sites interacting by way 
of  intracellular or retrograde messengers. 
These results are partially consistent with reports that ifenprodil and Ro 25-
6981  caused  small  inward  currents  produced  by  NMDA  1/J-M  to  be 
potentiated,  while  larger  currents  produced  by  NMDA  100/J-M  were 
markedly inhibited (Kew et at.,  1996; Fischer et at.,  1997).  However, no 
inhibition  against  any  concentrations  of NMDA  in  the  intact  neuronal 
network of the adult hippocampal slice was observed.  This is most simply 
109 explained  by  the  very  different  expressIOn  of  subunits  and  their 
phosphorylation within  cloned receptor constructs,  immature tissues  and 
with the mature tissue used in this study but merits further investigation. 
It also  appears  from  the  data in this  study that the  interaction between 
NR2B  and  NR2A  subunits  was  not  prevented  by  inhibitors  of protein 
kinases or the serine/threonine protein phosphatases types  1 and 2A (PP 1 
and PP2A) (Bialojan &  Takai,  1988).  A finding consistent with our later 
observation that Ro  25-6981  was unable to  block LTP  induction,  which 
requires  the  activation  of protein  kinases  (Bliss  &  Collingridge,  1993). 
Although  the  interaction  between  NR2B  and  NR2A  subunit-containing 
receptors was not prevented by the broad-spectrum protein kinase inhibitor 
staurosporine, it is nevertheless likely that constitutively active kinases are 
essential to  phosphorylate the unknown moiety to  maintain the inhibitory 
restraint  described.  The  subunit  interaction  does  appear  to  involve 
Ca
2+/calmodulin-dependent  phosphatase  2B  (calcineurin),  since  it  was 
prevented by cyclosporin A.  Ca1cineurin has  previously been shown to 
enhance  both  the  presynaptic  release  of  glutamate  and  postsynaptic 
responsiveness  to  it  (Yakel,  1997)  partly  by  altering  channel  gating 
properties and promoting desensitisation in cultured hippocampal neurons 
(Lieberman & Mody, 1994; Nichols et ai., 1994; Sihra et ai., 1995; Tong et 
ai.,  1995;  Victor  et  ai.,  1995).  Furthermore,  the  calcineurin  inhibitors 
cyclosporin  A  and  FK506  are  able  to  prevent  the  induction  of LTD 
110 (Mulkey et at.,  1994; Hodgkiss &  Kelly,  1995).  Interestingly, it has been 
reported  that  calmodulin-dependent  inhibition  of NMDA  receptors  will 
reduce the amplitude and time course of excitatory synaptic currents in 12-
day-old rat hippocampal NMDA receptors (Rycroft &  Gibb, 2002).  NR2 
subunits,  unlike  NRI  subunits,  are  known  to  be  highly  phosphorylated 
under  basal  conditions  (Hall  &  Soderling,  1997),  therefore  the 
phosphorylation  step  described  could be acting  directly upon the NR2A 
and/or  the  NR2B  subunit  to  produce  the  enhancement  of responses  to 
NMDA.  It is however possible that the phosphorylation site is elsewhere 
on the NMDA receptor complex, which has been reported from proteomic 
analysis to associate with at least 77 proteins (Husi et al., 2000) e.g. NRl, 
PSD-95, SAP 102, or at a non-NMDA site. 
The present work also reveals that the potentiating effect of Ro  25-6981  is 
not  dependent  upon  new  protein  synthesis,  although  it  is  expected that 
relevant proteins are constitutively present.  The reason for the slow onset 
and  apparently  irreversible  nature  of the  enhancement  effect  remains 
unclear.  It may be due for example to the Ro 25-6981 binding irreversibly, 
to  a persistent modification of the NR2B, NR2A or NRI  subunit that is 
then independent of Ro 25-6981  binding, to an irreversible uncoupling of 
the NR2B subunit from NR2A or to a change in NMDA receptor functional 
expression.  Radiolabelled forms of  Ro 25-6981 are unavailable at this time 
to investigate the possibility of  it binding irreversibly to the NR2B subunit. 
111 Chapter 4.  The NMDA subunit specificity of L  TP 
Introduction 
It is  widely accepted that  a persistent change in synaptic strength is  the 
cellular basis  of learning  and  memory  (Alkon  &  Nelson,  1990;  Kandel, 
1997).  Both long-term potentiation (LTP) and long-term depression (LTD) 
have now been shown to fulfil three out of  the four criteria that are required 
to  verify that they are both 'necessary and sufficient for the  information 
storage underlying the type of  memory mediated by the brain area in which 
that plasticity is observed'.  Alterations in synaptic strength are detectable 
after learning,  interfering with the induction and expression mechanisms 
results in concurrent interference  in learning,  and altering the pattern of 
synaptic weights after learning affects the ability of animals to remember a 
previously  learned  experience.  The,  unfulfilled,  fourth  criterion  is 
mimicry, where an implanted pattern of synaptic weights generates in the 
animal the behaviour of a specific recalled memory (Moser et aI.,  1998). 
LTP, first reported in the dentate gyrus (Lomo, 1966; Bliss & Lomo, 1973), 
has  since  been  demonstrated  in  all  three  excitatory  pathways  in  the 
hippocampus (Schwartzkroin &  Wester, 1975; Alger &  Teyler,  1976) and 
elsewhere in the eNS (Kuba & Kumamoto, 1990).  LTP is characterised by 
input specificity,  co-operativity and associativity, leading to  the proposal 
that LTP is a Hebbian process (Hebb, 1946), where the co-incident activity 
112 of pre- and  postsynaptic  neurones  is  required  to  increase  persistently 
synaptic strength.  LTP was first shown to be involved in the cellular basis 
of learning and memory with experiments to block L  TP in vivo coincided 
with  deficits  in hippocampal-dependent place  navigation  (Morris  et  aI., 
1986).  LTP induction in the CAl area is NMDA receptor dependent: it is 
triggered by NMDA receptor activation and blocked by NMDA receptor 
antagonism  (Collingridge  et  ai.,  1983).  AMPA  receptor-mediated 
depolarisation  of the  postsynaptic  cell  during  L  TP  induction,  by  high 
frequency stimulation (HFS), releases the Mg2+ block of NMDA receptors 
allowing Ca2+ to flow into the cell (Lynch et ai., 1983; Mayer et ai., 1984; 
Nowak et ai.,  1984; Malinow &  Miller,  1986; Wigstrom et ai.,  1986).  A 
large rise in Ca2+ in the postsynaptic spine sets off a cascade of events that 
results  in  LTP  (Bliss  &  Collingridge,  1993).  The induction of LTP  is 
widely  considered  to  be postsynaptic  and the  expression both pre- and 
postsynaptic  (Kullmann  &  Nicoll,  1992;  Manabe  et  ai.,  1993).  The 
maintenance of LTP is characterised by an early phase which is dependent 
on post-translational modifications and lasts for a few hours, followed by 
later phases which are dependent on de novo gene expression and protein 
synthesis that lasts for many hours (Krug et ai.,  1984; Otani et ai.,  1989; 
Nguyen  et  ai.,  1994).  LTP  can  persist  for  varying  amounts  of time 
dependent upon the induction protocol and the experimental model.  It has 
recently  been  demonstrated  that  stable  L  TP  can  last  for  up  to  a  year 
(Abraham et aI., 2002). 
113 There  is  much  evidence  that  supports  a  role  for  the  NR2B  subunit  in 
synaptic plasticity and specifically in LTP.  Increases in the expression of 
the  NR2B  and  not  of the  NR2A,  NR2C  or  NR2D  subunit  after  L  TP 
induction and the prevention of L  TP  induction in an NR2B  knock-down 
model  support  a role  for  the  NR2B  subunit  in  the  early  phase  of LTP 
(Thomas  et  al.,  1994;  Thomas  et  al.,  1996).  Furthermore,  enhanced 
tyrosine phosphorylation of the NR2B subunit has been demonstrated after 
the  induction  of LTP  (Rosenblum  et  aI.,  1996;  Manabe  et  al.,  2000; 
Nakazawa et aI.,  2001).  LTP  and LTD are bi-directional mechanisms of 
synaptic  plasticity,  induced  by different  patterns  of afferent  stimulation 
(Dudek  &  Bear,  1993).  A  recent  investigation was  made  into  whether 
these different patterns reflect the activation of  specific subunits to produce 
either LTD or LTP.  It was found that antagonists with a higher affinity for 
the  NR2AIB  subunits  over  the  NR2C/D  subunits  produced  greater 
inhibition of LTP than LTD induction (Hrabetova et aI.,  2000).  There are 
also reports that the NR2B subunit is  associated with age-related changes 
(Magnusson, 2000), the decrease in NR2B expression with increasing age 
leading  to  the  blockage  of L  TP  induction  and  impairments  in  spatial 
learning  performance  (Clayton  et aI.,  2002).  Potentiating  the  NMDA 
receptors  using  spermine,  an  endogenous  polyamine,  could  reverse  this. 
Taking  advantage  of  the  new  NR2B  and  NR2A  subunit-selective 
antagonists,  Ro  25-6981  and  PEAQX,  this  investigation  sought  to 
determine the subunit specificity ofNMDA-dependent LTP induction. 
114 Results 
L  TP  was  induced by high frequency  stimulation  (3  identical trains  of 1 
second stimulation bursts at 100Hz 10 minutes apart; HFS).  This produced 
an  enhancement  of fEPSP  slope  to  197.9±16.4%  (p<0.001,  n=6)  that 
persisted steadily for  140 minutes from the start of the induction protocol 
(figure 23 and 24). 
To  demonstrate  that  the  LTP  induced  by  HFS  was  NMDA  receptor-
dependent  50)lM  2-AP5  was  applied  during  the  induction protocol  and 
prevented LTP induction (figure 25).  PEAQX O.l)lM was then used, which 
had previously been seen in  chapter 3 to  block NMDA responses  in  an 
analogous manner to  2-AP5.  The perfusion of this NR2A antagonist also 
prevented the induction of LTP (figure 26).  Finally, the NR2B antagonist 
Ro 25-6981 was used but it was unable to prevent the induction of LTP to 
170.4±15.7% (p<O.Ol,  n=6) of baseline fEPSP  slope, which was less than 
control HFS induced LTP but not significantly so (figure 27). 
This result clearly demonstrates that the NR2A subunit, and not the NR2B 
subunit, is critically required for the induction of NMDA-dependent LTP 
(figure 28). 
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Figure 23.  Effect of high frequency stimulation on fEPSP slope. 
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~O 
Plot showing L  TP induced by three trains of stimuli using 100 pulses at 100 Hz, 
ten  minutes  apart  (HFS)  at 20,  30  and  40 minute  time  points,  producing  a 
persistent enhancement of the fEPSP slope to  197.9±16.4% of the control size 
(p<0.001, n=6).  Each point shows the mean±s.e.m. for n=6 experiments. 
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Figure 24.  Representative fEPSPs demonstrating L  TP. 
Illustrating baseline responses (c) and  potentiated responses (1) as  a result of 
L  TP induction; pOints correspond to figure 23. 
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Figure 25.  Blockade of NMDA-dependent L  TP induction by 2-AP5. 
Plot showing the perfusion of 2-AP5 50flM during the HFS induction protocol for 
L  TP  which  prevented  the  induction  of  L  TP,  n=3.  Each  point  shows  the 
mean±s.e.m. for n=3 experiments. 
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Figure 26.  Blockade of NMDA-dependent L  TP induction by PEAOX. 
Plot  showing  the  effect of PEAOX 0.1 J.lM  upon  the  induction  of L  TP.  The 
perfusion of PEAOX prevented  the  induction  of L  TP.  Each  point shows the 
mean±s.e.m. for n=4 experiments. 
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Figure 27.  Effect of Ro 25-6981  on NMDA-dependent L  TP induction. 
Plot  showing  that  the  application  of 3f-lM  Ro  25-6981  during  the  HFS-L  TP 
induction  protocol  was  unable  to  prevent  the  induction  of a  significant  L  TP 
(170.4±15.7% (p<O.01,  n=6) of baseline fEPSP  slope.  Each  point shows the 
mean±s.e.m. for n=6 experiments. 
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Figure 28.  Role of NR2A and NR2B subunits in long-term potentiation. 
Histogram  showing  L  TP  induction  by  high  frequency  stimulation  (HFS,  three 
stimulation trains of 100 pulses at 100 Hz, ten minutes apart).  Bath application 
of  either  SO\-lM  2-APS  or  0.1 \-1M  PEAQX  prevented  the  induction  of  LTP, 
whereas 3IJM  Ro 2S-6981  did  not,  reducing LTP to  170.4±1S.7% (p<O.01,  n=6) 
of baseline  fEPSP  slope.  This  was  not  significantly  less  than  L  TP  in  the 
absence of drugs (p=0.2S26, n=6), but was significantly greater than the original 
fEPSP baseline slope (**p<0.01, n=6). 
121 Discussion 
The  present  study  has  shown  that  NMDA  receptor-dependent  LTP 
induction  is  critically  dependent  upon  the  NR2A  subunit-containing 
receptor activation and not the NR2B  subunit in the  Schaffer collateral-
CAl  synapse.  This result is consistent with a recent report that LTP  is 
associated with the rapid surface expression of  postsynaptic NR2A subunit-
containing NMDA receptors (Grosshans et aI., 2002).  Additionally, whilst 
Ro  25-6981  does  not  block the induction of LTP,  the LTP  induced was 
marginally reduced consistent with a recent report (Kohr et aI., 2003). 
Several  reports  have  now  been  published  investigating  the  subunit 
selectivity ofLTP and LTD (Sjostrom et ai., 2003; Liu et ai., 2004; Massey 
et ai.,  2004;  Mallon  et aI.,  2005).  Liu  and  colleagues  reported that  at 
hippocampal  CAl  synapses  of 3-4  week  old  rats  LTP  was  blocked by 
PEAQX.  Furthermore, using an  LTP protocol pairing Schaffer collateral 
stimulation  with  postsynaptic  depolarisation  under  whole-cell  recording 
conditions LTP could be blocked by PEAQX and LTD was induced.  The 
induction of LTD has been reported to  be blocked by NR2B  antagonists, 
including  Ro  25-6981  and  ifenprodil  (Sjostrom  et aI.,  2003;  Liu  et  ai., 
2004;  Massey  et aI.,  2004).  However the  investigation of LTD  in this 
study was prevented because of the difficulty in induction of LTD in adult 
animals, in agreement with reports by other laboratories (Kemp &  Bashir, 
122 2001).  Massey  and  colleagues  reported  that  the  induction  of L  TP  and 
depotentiation in the perirhinal cortex of 7  -12 week old rat was blocked by 
PEAQX.  They  also  found  that  LTD  was  difficult  to  induce  but  that 
blockade of glutamate uptake, which led to the activation of postsynaptic, 
extrasynaptic NR1/NR2B receptors, overcame this obstacle.  This allowed 
the induction of LTD, which could also be prevented by Ro  25-6981, the 
NR2B  antagonist.  However, the distribution of NMDA receptor subunits 
varies  widely  developmentally  and  between  brain  regions  and  synaptic 
pathways (Otmakhova et a!.,  2002; Arrigoni &  Greene, 2004).  Therefore, 
different local conditions can regulate the sensitivity and characteristics of 
synaptic plasticity to different NR2 subunits.  It has also been reported that 
LTP is sensitive to NR2B antagonists in the young Schaffer collateral-CAl 
synapse (R.  Malenka, personal communication), visual cortex (Yoshimura 
et al.,  2003),  amygdala (T.  Sigurdsson, personal communication) and the 
hippocampal  commissural-CA3  synapse  (Ito  et al.,  2000).  The  NR2B 
subunit, unlike the NR2A subunit-containing receptors or AMPA receptors, 
seem to be of particular importance in regulating learning and memory and 
have recently been reported to be differentially distributed in the left-right 
asymmetry of the brain, which has important implications for higher order 
functions (Kawakami et al., 2003; Shinohara et al., 2003). 
123 Chapter 5.  The NR2A & NR2B subunit-selectivity 
of homoquinolinic acid 
Introduction 
The tryptophan metabolite, quinolinic acid (QA), has been recognized for 
many years to  be a weak, endogenous NMDA receptor agonist (Stone & 
Perkins, 1981; Stone,  1984;  1993).  Shortly after its discovery, a study of 
structure-activity  relationships  among  a  series  of  related  compounds 
revealed that a close analogue, homoquinolinic acid (HQA), had a potent 
excitatory activity.  Indeed, HQA appeared to be between 10  and 100-fold 
more  potent  at  activating  glutamate  receptors  (Stone,  1984). 
Autoradiographical  and  electrophysiological  studies  have  recently  been 
undertaken on native and recombinant receptors to  evaluate the  subunit-
specificity of HQA.  It has been reported from electrophysiological studies 
that HQA is a potent NMDA receptor agonist that has a higher affinity for 
Xenopus  oocytes  expressing  NR2A  and  NR2B  subunit-containing 
receptors,  compared  to  NR2C  and  NR2D  subunit-containing  receptors 
(Buller &  Monaghan,  1997).  A recent study also found that HQA had an 
approximately  2-fold  higher  affinity  for  NR1a/NR2B  and 
NR1 a/NR2A/NR2B  receptors  compared to  NR1 a/NR2A  receptors  (EC50 
13.8, 9.04 and 25.2JlM, respectively).  Yet showed greater intrinsic activity 
for  NR1 a/NR2A  and  NR1 a/NR2A1NR2B  compared  to  NR1 a/NR2B 
124 transfected receptors  (compared to  glutamate responses  (100%),  148±15, 
125±5.6  and  93.3±4%,  respectively)  (Grimwood  et  al.,  2002).  In 
autoradiographical studies, it has been observed that 3[H]-homoquinolinic 
acid  selectively  radiolabels  a  subpopulation  of NMDA  receptors  in  rat 
brain  that  is  consistent  with  the  distribution  of the  NR2B  subunit  and 
clearly dissimilar to  NR2C and NR2D subunit distribution (Buller et al., 
1994;  De Carvalho  et al.,  1996;  Brown et al.,  1998),  although there are 
contradictory reports where HQA was  not  as  highly  specific  for  NR2B-
containing  receptors  (Grimwood  et  al.,  2002).  In  radioligand  binding 
studies 3[H]-HQA also bound to a novel binding site from which it was not 
displaced  by  NMDA  or  glutamate  but  was  displaced  by  2-carboxy-3-
carboxymethylquinoline (CCMQ), a HQA derivative (Brown et ai.,  1998; 
Grimwood et al., 2002).  The identity and function of  this proposed site are 
unknown. 
This  investigation  was  designed  to  establish  whether  there  was  any 
evidence  for  this  unidentified  site  in the  generation of evoked  synaptic 
potentials  in  the  hippocampal  slice.  Additionally,  by  using  an 
NR2A1NR2B  subunit-containing  NMDA  receptor  agonist  (HQA)  to 
investigate  subunit-pharmacology in combination with NR2A and NR2B 
subunit-selective  antagonists  (PEAQX  and  Ro  25-6981)  this  study  can 
consider the role of NR2D subunit-containing receptors on the depression 
of  fEPSP slope and paired-pulse interactions. 
125 Results 
HQAand QA 
In order to  determine the most suitable concentrations of agonists to use 
concentration-response curves  were  constructed from  which it was  clear 
that HQA and QA gave useful  depressions of approximately 50% of the 
baseline fEPSP slope at 2.5~M  and l50~M  respectively (figures 29-31, 34-
36).  These concentrations were selected for further experiments since both 
increases and decreases of the depression of fEPSP  slope could easily be 
observed.  The depression elicited by the application of HQA  2.5~M and 
QA  l50~M both  coincided  with  a  significant  decrease  of paired-pulse 
inhibition  and  increase  of paired-pulse  facilitation  at  all  interstimulus 
intervals (HQA:  10ms p<O.Ol,  20ms p<O.OOl,  50ms p<O.OOl,  n=lO;  QA: 
10ms p<0.05; 20ms p<O.OOl; 50ms p<O.OOl; n=7) (figures 32,33,37,38). 
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Figure 29.  The concentration-response curve of HQA. 
A plot showing concentration-response curve for homoquinolinic acid-produced 
depression of the fEPSP slope at 1,  2,  2.5,  3 and  4IJM  (n  = 3,  5,  8,  5 and 4, 
respectively).  The concentration  inducing  a 50%  reduction  is  2.4  IJM.  Each 
point shows the mean±s.e.m. 
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Figure 30.  Effect of HQA 2.5f-LM on fEPSP slope. 
A  plot  of fEPSP  slope  showing  that  homoquinolinic  acid  2.51JM  caused  a 
depression  of normalised  fEPSP  slope  to  approximately 50%  (here  45.4%  ± 
8.12,  p  <  0.01,  n  =  8)  relative  to  control  responses.  Each  point shows  the 
mean±s.e.m. for n=8 experiments. 
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Figure 31.  Representative fEPSPs showing effect of 2.51JM HQA. 
fEPSPs  corresponding  to  baseline  (c)  responses  and  during  the  depression 
elicited by HQA 2.51JM (1) in the time course of figure 30. 
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Figure 32.  Effect of 2.51JM HQA on paired-pulse interactions. 
Shows the paired-pulse interactions of fEPSP slope at interstimulus intervals of 
10ms,  20ms  and  50ms  during  the  depression  elicited  by  HQA  2.5~M.  The 
results are presented as the interactions during baseline control responses (c), 
the effect of homoquinolinic acid  2.5~M (1) and the washout period  (2)  (1 Oms 
p<0.01,  20ms  p<0.001,  50ms  p<0.001,  compared  to  baseline  control 
responses, n=10), points correspond to the time course of figure 30.  The data 
show  a  loss  of paired-pulse  inhibition  at  10ms,  and  increased  paired-pulse 
facilitation  at 20  and  50ms  caused  by  homoquinolinic acid.  *P  < 0.05,  **P  < 
0.01, ***P < 0.001.  Each point shows the mean±s.e.m. for n=10 experiments 
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Figure 33.  Example records of fEPSPs during paired-pulse interactions. 
During  baseline  recording:  (a)  10ms  (b)  20ms  and  (c)  50ms  and  during  the 
depression elicited by HQA 2.5~M: (d) 10ms (e) 20ms and (f) 50ms. 
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Figure 34.  The concentration-response curve of QA. 
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A  plot  showing  the  concentration-response  curve  of the  fEPSP  slope  to  5-
minute applications of QA:  10,  50,  100,  150, 300 and  1  OOO~M (n=4,  3,  6,  8,  3, 
and 4  respectively).  The concentration inducing a 50%  reduction  is  157.2IlM. 
Each point shows the mean±s.e.m. 
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Figure 35.  Effect of 150l-lM QA on fEPSP slope. 
A plot of fEPSP slope showing that quinolinic acid  150l-lM caused a depression 
of normalised fEPSP slope to 55.7%±8.12% (p=O.0017;  n=8) relative to control 
responses.  Each point shows the mean±s.e.m. for n=8 experiments. 
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Figure 36.  Representative fEPSPs showing the effect of QA 150\JM. 
fEPSPs  corresponding  to  baseline  (c)  responses  and  during  the  depression 
elicited by QA 150\JM (1) in the time course of figure 35. 
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Figure 37.  Effect of QA on paired-pulse interactions. 
Shows paired-pulse interactions of the fEPSP slope  under resting  conditions, 
(c),  in  the  presence of quinolinic acid  150  !-1M  (1),  and  during  washout  (2). 
Quinolinic acid caused a significant decrease of paired-pulse inhibition at 10ms, 
and  a  facilitation  of  the  paired-pulse  ratio  at  greater  intervals.  Points 
correspond  to  in  the time course of figure 35.  *P  <  0.05,  **P < 0.01,  ***P < 
0.001  compared  to  baseline  control  responses.  Each  point  shows  the 
mean±s.e.m. for n=7 experiments. 
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Figure 38.  Example records of fEPSPs during paired-pulse interactions. 
During  baseline  recording:  (a)  10ms  (b)  20ms  and  (c)  50ms  and  during  the 
depression elicited by QA 150jJM: (d) 10ms (e) 20ms and (f) 50ms. 
136 DPCPX 
Adenosine  is  a  neuromodulator  with  an  important  role  in  synaptic 
transmission  and  neuronal  excitability,  inhibiting  transmission  via  the 
activation  of presynaptic  Al  receptors  by decreasing  release  probability 
which  enhances  the  paired-pulse  interaction  (Dunwidde,  1985;  Greene, 
1991).  1,3-dipropyl-8-cyclopentyl-xanthine  (DPCPX)  is  a  potent  and 
selective  adenosine  Al  receptor  antagonist  (Linden,  1991).  Since  the 
depolarisation of excitable tissues  elicits the release of adenosine,  it  was 
important to confirm that the depression of fEPSP slope and the associated 
changes in paired-pulse interactions were indeed directly attributable to the 
activation  of NMDA  receptors  and  not  to  the  release  of endogenous 
adenosine. 
An  initial  application  of HQA  2.5/-lM  caused  a  depression  of baseline 
fEPSP  slope to  13.13±3.88% (p<O.OOI,  n=5).  In the presence of DPCPX 
20nM,  a concentration that  selectively blocks adenosine Al  receptor,  the 
second  application  of  HQA  2.5/-lM  caused  a  similar  depression  to 
15.20±7.04% (p<O.OOI,  n=5) compared to  baseline responses (figure 39). 
During  the  initial  HQA  application  the  paired-pulse  interactions  were 
significantly  enhanced  at  all  interstimulus  intervals  (p<O.O 1,  n=5  at  all 
intervals) compared to  baseline control responses.  The co-application of 
DPCPX during the second application of HQA produced an exactly similar 
137 effect (p<0.01, n=5 at all intervals) compared to baseline control responses 
(figure 40).  This suggests that the presynaptic element of  the depression of 
fEPSP slope is not dependent upon the activation of presynaptic adenosine 
Al receptors. 
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Figure 39.  Effect of DPCPX upon HQA-evoked depression of fEPSP slope. 
A  plot  of fEPSP  slope  showing  the  depression  of baseline  (c)  fEPSP  slope 
caused  by  HQA 2.5/lM  alone  (1),  and  in  the  presence  of DPCPX 20nM  (2). 
Each point shows the mean±s.e.m. for n=5 experiments. 
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Figure 40.  Effect of HQA and DPCPX upon paired-pulse interactions. 
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2 
c 
Showing the paired-pulse interactions of fEPSP slope at interstimulus inteNals 
of 10ms, 20ms and 50ms; the results are presented as HQA 2.5~M (1) (p<0.01, 
n=5  at  all  inteNals)  and  HQA  2.5~M in  the  presence  of DPCPX  20nM  (2) 
(p<0.01, n=5 at all inteNals) both produced significant enhancements of paired-
pulse  interactions  compared  with  baseline control  responses  (c).  Each  point 
shows the mean±s.e.m. for n=5 experiments. 
140 Inhibition by kynurenic acid, 2-AP5 and dizocilpine 
The broad-spectrum EAA antagonist, kynurenic acid (KYA)  100/-lM, was 
used at a concentration that selectively blocks NMDA and not AMP  A or 
kainate receptors  (Perkins  &  Stone,  1982;  Stone &  Burton,  1988).  This 
blocked the depressant effect of both QA and HQA on the evoked tEPSP 
with no  residual response that might indicate a novel binding site (figure 
41).  The  selective  and  competitive  NMDA  receptor  antagonist  2-APS 
SO/-lM  was  used,  which also  blocked the  effect of both QA  lSO/-lM  and 
HQA  2.S /-lM  but  again  left  no  residual  effect  upon  the  evoked  tEPSP 
(p<0.001 and p<O.OOl; respectively, n=4) (figure 42). 
It was thought that the concentration of  HQA required to activate the novel 
binding  site  might  be  higher  than  that  required  for  NMDA  receptor 
activation,  but that  raising  the  agonist  concentration  would  simply  out-
compete  the  blockade  of 2-APS.  Therefore,  the  selective  and  non-
competitive NMDA receptor antagonist dizocilpine (MK 801)  10/-lM was 
used,  which  produces  a  voltage  and  use-dependent  non-competitive 
blockade of the NMDA receptor ion-channel.  This blockade allowed the 
increase by 10-fold the concentration of both QA and HQA to  1.SmM and 
2S /-lM  respectively so that any novel binding site should be more strongly 
activated.  The  blockade  of the  NMDA  receptor  was  confirmed  using 
NMDA itself at  10/-lM.  However, in the presence of MK 801  these high 
141 concentrations of agonists  still  did not induce any observable changes in 
the fEPSP.  Unfortunately, it was not possible to perform control responses 
to  these  higher  concentrations  of QA  and  HQA  because,  without  the 
presence  of  the  antagonist,  they  produced  a  complete  and  largely 
irreversible loss of  the fEPSP, through excitotoxic neuronal damage (figure 
43). 
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Figure  41.  Effect of kynurenic acid  on  QA  and  HQA-induced  depressions of 
fEPSP slope. 
Representative  plot  showing  the  blockade  by  kynurenic  acid  1  OO~M of the 
depression of fEPSP slope caused by QA 150~M  and HQA 2.5~M. 
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Figure 42.  Effect of 2-AP5 on QA and HQA on fEPSP slope. 
A  plot  showing  the  depression  of  fEPSP  slope  during  the  application  of 
quinolinic  acid  150J-LM  and  homoquinolinic  acid  2.5J-LM  and  their subsequent 
inhibition by 2-AP5 50J-LM  (P < 0.001 and  P < 0.001;  respectively).  Each  point 
shows the mean±s.e.m. for n=4 experiments. 
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Figure 43.  Effect of MK 801  on QA and HQA on fEPSP slope. 
A  plot showing the  inhibition  by MK 801  10llM of the  depressant effect upon 
fEPSP slope by NMDA 10IlM, QA 1.5mM and  HQA 251lM.  Each point shows 
the mean±s.e.m. for n=4 experiments. 
145 Ro 25-6981 
As  illustrated  in  figure  44,  HQA  2~M (i)  and  QA  100~M (1)  are 
concentrations that produced small yet discernible depressions of baseline 
fEPSP  slope (c).  With the  co-perfusion of Ro  25-6981  3~M, the same 
concentrations of QA (2) and HQA (ii) produced significant depressions of 
the fEPSP slope to 24.19±15.39% and -1.88±4.93% respectively compared 
to baseline responses (p<O.OOl  and p<O.OOl  respectively n=5).  Ro 25-6981 
was then allowed to wash out and QA (3) and HQA (iii) were re-applied 
where a significant depression to 8.98±5.21 % and -5.59±4.04% of control 
respectively was  still  observed  (p<O.OOl  and p<O.OOl  respectively  n=5) 
(figure 44).  It was noticed that the effect of  Ro 25-6981 seemed to develop 
slowly and did not diminish during the washout phase of  the experiment.  It 
was  also  observed  that  paired-pulse  interactions  were  significantly 
enhanced  during  the  enhanced  depressions  of  QA  and  HQA  at  all 
interstimulus  intervals  after the application  of Ro  25-6981  compared to 
during  the  initial  applications  (QA:  10ms  p<O.Ol,  20ms  p<O.05,  50ms 
p<O.Ol; HQA: 10ms p<O.OOl, 20ms p<O.OOl, 50ms p<O.05, n=6; figure 45 
and 46). 
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Figure 44.  Effect of Ro 25-6981 with QA and HQA on fEPSP slope. 
A  plot showing  the  effect of QA  100IJM  (1)  and  homoquinolinic acid  2IJM  (i) 
compared to the baseline fEPSP response (c).  During the co-perfusion of Ro 
25-6981  3~M, the same concentrations of QA (2) and  homoquinolinic acid  (ii) 
produced  a  significant depression  to  24.19±15.39%  and  -1.88±4.93%  of the 
fEPSP  slope  respectively  compared  to  baseline  responses  (p<0.001 and 
p<0.001  respectively).  Ro  25-6981  was then  washed  out for 20  minutes until 
QA (3)  was  re-applied  and  45  minutes  until  homoquinolinic acid  (iii)  was  re-
applied  where  a  significant  depression  to  8.98±5.21 %  and  -5.59±4.04% 
respectively  was  observed  compared  to  the  baseline  fEPSP  responses 
(p<0.001  and p<0.001  respectively).  Each point shows the mean±s.e.m. 
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Figure 45.  Effect of Ro 25-6981  and QA on paired-pulse interactions. 
A plot showing the paired-pulse interactions at interstimulus intervals of 10ms, 
20ms  and  50ms  during  baseline  recordings  (c),  the  initial  application  of QA 
100~M (1)  and  the  second  application  of QA  100~M during the  co-perfusion 
with  Ro  25-6981  3~M (2)  (10ms  p<0.01,  20ms  p<0.05,  50ms  p<0.01,  n=6). 
Points correspond to figure 44.  *P < 0.05, **P < 0.01, ***P < 0.001.  Each point 
shows the mean±s.e.m. for n=6 experiments. 
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Figure 46.  Effect of Ro 25-6981  and HQA on paired-pulse interactions. 
Showing the paired-pulse interactions at interstimulus intervals of 10ms, 20ms 
and  50ms during baseline recordings (c), the initial application of HQA 2~M (i) 
and the second application of HQA 2~M  during the co-perfusion of Ro 25-6981 
3~M  (ii) (10ms p<0.001, 20ms p<0.001, 50ms p<0.05, n=6).  Points correspond 
to  figure  44.  *P  <  0.05,  **P  <  0.01,  ***P  <  0.001.  Each  point  shows  the 
mean±s.e.m. for n=6 experiments. 
149 Excitotoxicity 
An application of HQA that significantly depressed the fEPSP  slope was 
selected to investigate the effect of  Ro 25-6981 on higher concentrations of 
NMDA receptor agonists.  In previous studies of  young cultured rat cortical 
neurones Ro 25-6981 had potentiated small depolarising concentrations of 
NMDA  but  blocked  larger  depolarising  concentrations  (Fischer  et  al., 
1997).  A 5-minute application of  HQA 4/-lM caused a maximal depression 
offEPSP slope to 6.63±3.69% (p<0.001, n=4) that reverted to near baseline 
responses upon washout.  Ro 25-6981 3/-lM was co-perfused with a second 
application of 4/-lM HQA which produced a depression of fEPSP  slope to 
-9.27±1.13%  (p<0.001,  n=4).  However,  this  depression  did  not  fully 
recover to baseline responses.  The fEPSP slope was irreversibly reduced to 
an average 34.70±0.38% compared to baseline responses (p<0.001, n=4). 
Maximum evokable amplitudes of fEPSP slope (100%), which were taken 
as an additional measure of excitotoxic damage, were significantly reduced 
(p=O.OOll,  n=4)  compared to  the baseline maximums recorded and they 
did not recover during  the  70-minute washout phase of the  experiment. 
Attempts to  induce L  TP  at the end of the experiments also  failed,  again 
suggesting that irreversible excitotoxic damage had occurred (figure 47 and 
48).  This  specifically  ruled  out  the  induction  of  NMDA-receptor 
dependent LTD, which was reversible by high frequency stimulation (data 
not shown). 
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Figure 47.  Effect of HQA 4J.!M and Ro 25-6981  on fEPSP slope. 
A  5-minute  application  of  homoquinolinic  acid  4J.!M  elicited  a  reversible 
depression  of baseline  fEPSP  slope  to  6.63±3.69%  (p<O.001).  Ro  25-6981 
3J.!M was co-perfused and a second 5-minute application of homoquinolinic acid 
4J.!M  produced  a  depression  of  fEPSP  slope  to  -9.27±1.13%  (p<O.001). 
However,  the  fEPSP  slope  did  not  fully  recover  but  was  significantly  and 
irreversibly reduced to an average 34.70±O.38% compared to the initial baseline 
(p<O.001).  Each  point  shows  the  mean±s.e.m.  for  n=4  experiments. 
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Figure 48.  Representative fEPSP recordings showing excitotoxicity. 
During  baseline  recording  (c)  and  during  the  irrecoverable  depression  (1) 
corresponding to figure 47. 
152 NR2A antagonists 
HQA is  reported to  be a selective agonist for NR2A and NR2B  subunit-
containing NMDA receptors.  Using Ro  25-6981, an NR2B antagonist, to 
produce  the  potentiation  of  the  depression  of  fEPSP  slope  by  low 
concentrations of HQA suggests that the remaining HQA-dependent effect 
could be modulated by the remaining NR2A component of HQA activity. 
In order to  test this theory several  candidate NR2A selective antagonists 
including zinc, CCMQ and PEAQX were investigated (Paoletti et aI.,  1997; 
Brown et ai., 1998; Auberson et ai., 2002; Grimwood et aI., 2002). 
CCMQ 
Previous  autoradiographical  studies  found  that  2-carboxy-3-
carboxymethylquinoline (CCMQ),  a derivative of HQA,  displaces bound 
eH]-HQA from its NMDA-insensitivenovel binding site at a concentration 
of 1mM,  leaving  behind  a binding  pattern which  closely  resembles  the 
distribution  of NR2B  subunits  in  the  rat  brain  (Brown  et  ai.,  1998; 
Grimwood et ai.,  2002).  These results and the structural homology with 
HQA suggest that CCMQ may be able to  displace HQA from the NR2A 
subunit-containing  NMDA  receptors  thereby  leaving  only  the  NR2B 
population, acting as an NR2A-selective ligand. 
153 The effect of CCMQ 0.5mM upon the HQA-induced depression of fEPSP 
slope was investigated first.  As shown in figure 49 two initial applications 
of HQA  2.5 f.lM  produced two  similar depressions  of fEPSP  slope.  The 
third application of  HQA was co-applied with CCMQ but this had no effect 
on an identical depression of fEPSP slope.  This suggests that CCMQ was 
not acting as an antagonist of  the NR2A site activated by HQA.  This study 
next investigated if CCMQ was an NR2A agonist and used Ro 25-6981 to 
block the NR2B  subunit  in  order to  help  reveal  any  NR2A  effect.  As 
shown in figure 50 the perfusion of Ro 25-6981  alone had no effect upon 
baseline fEPSP slope but CCMQ elicited a small potentiation of  the fEPSP 
slope  to  108.65±1.71 %  (p=0.0058,  n=3).  Finally,  the  effect  of CCMQ 
upon  the  potentiation  of HQA  2f.lM  caused  by  Ro  25-6981  3  f.lM  was 
investigated in order to  address the subunit specificity of this potentiation. 
As  shown  in  figure  51  the  application  of HQA  2f.lM  produced  little 
response but the application of Ro 25-6981 potentiated this to a significant 
depression  to  14.72±10.49%  (p<O.OOI,  n=3)  of baseline  fEPSP  slope, 
which was not inhibited by CCMQ.  The co-perfusion of CCMQ resulted 
again  in  the  same  small  but  significant  increase  in  fEPSP  slope  to 
124.25±2.75% (p<O.05, n=3).  A third application ofHQA 20 minutes after 
the end of the perfusion of  Ro 25-6981  also produced a large depression to 
7.18±3.24% (p<O.OOI, n=3) offEPSP slope. 
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Figure 49.  Effect of HQA 2.5~M and CCMQ O.5mM on fEPSP slope. 
100 
A  plot  showing  the  effect of repeated  5-minute  perfusions  of homoquinolinic 
acid  2.5~M, that caused  three  consecutive  depressions  of the  fEPSP  slope. 
The  co-perfusion  of CCMQ  O.5mM  with the  third  perfusion  of homoquinolinic 
acid  had  no  significant  effect  upon  the  peak  magnitude  or  duration  of the 
response.  Each point shows the mean±s.e.m. for n=3 experiments. 
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Figure 50.  Effect of CCMQ and Ro 25-6981  on fEPSP slope. 
A plot showing the effect of 3jJM  Ro 25-6981  and the subsequent co-perfusion 
of O.5mM  CCMQ which  produced  a  small  potentiation  of the fEPSP  slope to 
108.65±1.71 %  (p=O.0058).  Each  point  shows  the  mean±s.e.m.  for  n=3 
experiments. 
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Figure 51.  Effect of HQA 2f.lM, Ro 25-6981  and CCMQ 0.5mM on fEPSP slope. 
Plot showing that the first application of HQA 2f.lM  produced little response but 
the  co-application  of  Ro  25-6981  potentiated  a  second  HQA-application 
producing a significant decrease to 14.72±10.49% (p<0.001) of baseline fEPSP 
slope.  The  co-perfusion  of  CCMQ  again  resulted  in  the  same  small  but 
significant  increase  in  fEPSP  slope  to  124.25±2.75%  (p<0.05).  A  third 
application of HQA 20 minutes after the end of the perfusion of Ro 25-6981  also 
produced  a large depression to  7.18±3.24% (p<0.001) of fEPSP slope.  Each 
point shows the mean±s.e.m. for n=3 experiments. 
157 Zinc 
Zinc  ions  (Zn
2+)  have  been  reported  to  produce  a  selective  and  non-
competitive  inhibition  of  the  NR2A  subunit-containing  recombinant 
NMDA receptors, producing a voltage-independent inhibition at nanomolar 
concentrations (Paoletti  et  aI.,  1997).  As  shown in figure  52  an  initial 
application of HQA 2.5 JlM caused a significant depression of fEPSP slope 
to  O.7±O.57%  (p<O.OOl,  n=4)  ,  a  second  application  of HQA with  Zn
2
+ 
100nM also produced an identical depression of fEPSP slope to 2.6±2.2% 
(p<O.Ol, n=4).  Thus, 100nM Zn
2
+ was unable to prevent the depression of 
fEPSP slope. 
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Figure 52.  Effect of HQA 2.5flM and Zn
2
+ 100nM on fEPSP slope. 
A  plot showing  that the  first  application  of HQA  2.5flM  caused  a  significant 
depression  of  baseline  fEPSP  slope  to  O.7±O.57%  (p<O.001).  A  second 
application of 2.51JM  HQA with 100nM Zn
2
+ again produced a similar depression 
of fEPSP slope to  2.6±2.2% (p<O.01).  Each point shows the mean±s.e.m. for 
n=4 experiments. 
159 PEAQX 
Having been unsuccessful with CCMQ and zinc in attempts to antagonise 
the NR2A subunit, PEAQX, a novel NR2A antagonist was  obtained as  a 
gift from Dr Yves Auberson of Novartis Pharmaceuticals.  This compound 
has  l26-fold  selectivity  for  the  NMDA  NRlAINR2A  over  the 
NRlAINR2B receptors expressed in Xenopus oocytes (ICso  =  l4nM and 
l800nM  respectively)(Auberson  et  al.,  2002).  This  investigation  was 
started by constructing a  concentration-response  curve  for  the inhibitory 
effect of PEAQX upon the depression of fEPSP  slope elicited by HQA 
3  ~M. This was achieved by applying 3  ~M  HQA, which produced a large 
depression of  the fEPSP slope, and then PEAQX was co-applied at varying 
concentrations.  Subsequent co-applications of the same concentration of 
HQA were made and the  degree  of antagonism produced was  observed 
(figures  53  and  54).  From  the  concentration-response  curve  it  was 
determined that using a concentration of  0.1 ~M  provided the most selective 
and  complete  antagonism  of  the  NR2A  subunit-containing  NMDA 
response.  This concentration-response curve is very similar to that found 
for the effect of PEAQX on NMDA-induced currents in Xenopus oocytes 
expressing human NRlAl2A subunits (Appendix 2). 
This study also investigated paired-pulse interactions during the interaction 
of HQA and PEAQX.  It was found that during the initial depression of 
160 fEPSP slope caused by HQA 3 JlM the paired-pulse ratios were increased at 
all  interstimulus  intervals  (lOms  p<O.OOI,  20ms  p<O.OI,  50ms  p<O.OOI; 
n=6) but that during the subsequent co-application of PEAQX 0.1 JlM  and 
HQA 3  JlM they remained similar to baseline responses (figure 55). 
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Figure 53.  Effect of HQA and  PEAQX on fEPSP slope. 
A  plot  showing  that  the  control  application  of  HQA  31lM  (1)  produced  a 
significant depression of baseline fEPSP slope (c) to 20.44±O.59% (p=O.0019). 
The  depression  of fEPSP  slope  expected  by  the  second  application  of HQA 
31lM  was  prevented  by  the  co-application  of PEAQX  O.1j..1M  (2),  Each  point 
shows the mean±s.e.m. for n=6 experiments. 
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Figure  54.  The  concentration-response  curve  of PEAQX  on  HQA-induced 
depression of fEPSP slope. 
A  plot  showing  the  concentration-response  curve  of the  inhibitory  action  of 
PEAQX at concentrations of 1  nM,  5nM,  10nM, 50nM,  100nM and 500nM (n=3 
at all intervals, except n=6 for 100nM PEAQX) upon HQA 3f.lM,  which normally 
caused a significant depression of fEPSP slope.  A concentration of 9.23nM is 
predicted to produce a 50%  inhibition of the depression elicited  by  HQA 31JM. 
Each point shows the mean±s.e.m. 
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Figure 55.  Effect of HQA and  PEAQX on paired-pulse interactions. 
c 
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A  plot  showing  the  paired-pulse  interactions  during  baseline  responses  (c), 
which were significantly enhanced at interstimulus intervals of 10ms, 20ms and 
50ms during the first application of HQA 3~M  (1) and  returned to control levels 
during the blockade of the second application of HQA  3~M by  PEAQX 0.11JM 
(2).  Points correspond  to the time-course in  figure 53.  Each  point shows the 
mean±s.e.m. for n=6 experiments.  *P < 0.05, **P < 0.01, ***P < 0.001. 
164 PEAQX's inhibition of the Ro 2S-6981/HQA potentiation. 
However, of greater interest was the finding that the potentiated depression 
of fEPSP  slope obtained by HQA  2~M  with Ro  25-6981  3  ~M  was  also 
completely  blocked  by  PEAQX  0.1~.  As  shown  in  figure  56,  a 
concentration of  2~M  HQA (1) initially produced a small and insignificant 
depression of the baseline fEPSP slope (c) but following the perfusion of 
Ro  25-6981  3  ~M, a  second  application  of HQA  2~M (2)  produced  a 
significant depression  of fEPSP  slope  to  37.33±4.43%  (p=O.0261,  n-4). 
The co-perfusion of PEAQX  O.l~M prevented the  depression of a third 
application of  HQA 2~M  (3). 
It  was  also  observed  that  paired-pulse  interactions  during  the  first 
application of HQA 2~M  (1) were not significantly different from baseline 
responses  (c).  However,  after the  application of Ro  25-6981  3~M, the 
second application of HQA 2~M  (2) caused a significant enhancement of 
paired-pulse ratios (p<O.OOI, n=4 at all interstimulus intervals).  During the 
inhibition by PEAQX  O.I~M, the third application of HQA 2~M  (3)  saw 
paired-pulse interactions remain similar to baseline responses (figure 57). 
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Figure 56.  Effect of HQA, Ro 25-6981 and PEAQX on fEPSP slope. 
A plot showing the effect of a low concentration of homoquinolinic acid 2JlM (1) 
that initially produced  a small,  insignificant depression  of the  baseline fEPSP 
slope (c).  Following the perfusion of Ro  25-6981  3JlM,  a second application of 
homoquinolinic acid 2JlM  (2) produced a significant depression of fEPSP slope 
to  37.33±4.43%  (p=O.0261).  The  co-perfusion  of PEAQX  O.1JlM,  an  NR2A 
selective  antagonist,  inhibited  the  depression  of  the  third  application  of 
homoquinolinic  acid  2JlM  (3).  Each  point  shows  the  mean±s.e.m.  for  n=4 
experiments. 
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Figure  57.  Effect  of  HQA,  Ro  25-6981  and  PEAQX  on  paired-pulse 
interactions. 
This plot shows the paired-pulse interactions recorded during the co-perfusions 
of HQA 2/lM, Ro  25-6981  3/lM and  PEAQX 0.1IJM.  Points correspond to the 
time course of figure 56.  Paired-pulse interactions during the first application of 
homoquinolinic  acid  2/lM(1)  were  not  significantly  different  from  baseline 
responses (c).  However,  after the application of Ro  25-6981  3/lM the second 
application  of homoquinolinic  acid  2/lM  (2)  caused  an  enhancement  of the 
paired-pulse  interactions  at  10ms  (p<0.001),  20ms  (p<0.001)  and  50ms 
(p<0.001)  compared  to  baseline  interactions.  During  the  NR2A inhibition  of 
PEAQX the third  application  of homoquinolinic  acid  2/lM  (3) saw the  paired-
pulse  interactions  return  to  baseline  responses  (n=4).  Each  point shows the 
mean±s.e.m. for n=4 experiments. *P < 0.05, **P < 0.01, ***P < 0.001.  Points 
correspond to the time course in figure 56. 
167 Protein synthesis 
In view of the latency of onset, the long-lasting effect of Ro  25-6981  and 
the  involvement  of a  protein  phosphatase  signal  transduction  step  the 
question  arose  of whether  any  new  protein  synthesis  was  required  and 
induced.  To investigate this possibility anisomycin 30f.lM was used, which 
has previously been shown to  block the maintenance of L  TP  and LTD at 
this  concentration and  over this  timescale (Grollman,  1967;  Otani  et at., 
1989;  Manahan Vaughan et at.,  2000;  Karachot et at.,  2001).  An initial 
application  of HQA  2f.lM  caused  a  small  depression to  82.68±3.l6% of 
baseline fEPSP slope.  Anisomycin 30f.lM and the subsequent co-perfusion 
of Ro 25-6981  3  f.lM had no significant effect on the baseline fEPSP slope. 
A  second  application  of HQA  2f.lM  produced  a  large  and  significant 
depression of fEPSP  slope to 0.91±3.0% (p=0.0152, n=4) compared to the 
initial application of HQA 2f.lM.  A similar profound depression of fEPSP 
slope to  6.05±4.86%  (p=0.0128,  n-4)  , again in  comparison to  the  initial 
application of HQA 2f.lM, was obtained with a subsequent application of 
HQA  2f.lM (figure 58).  This  suggests  that new  protein  synthesis  is  not 
required for the potentiation by Ro 25-6981. 
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Figure 58.  Effect of HQA, Ro 25-6981  and anisomycin upon fEPSP slope. 
Plot showing  that an  initial  application  of homoquinolinic  acid  2~M caused  a 
small  depression of baseline fEPSP  slope,  the perfusion  of anisomycin  30~M 
and  subsequent co-perfusion of Ro  25-6981  3~M had  no  significant effect on 
the baseline fEPSP slope.  The second application of homoquinolinic acid  2~M 
produced a depression to 0.91±3.04% (p=0.0152,n=4) compared to the trough 
of the initial application of homoquinolinic acid  2~M.  After washing out for 20 
minutes  a  further  application  of homoquinolinic  acid  2~M caused  a  similar 
depression of fEPSP slope to 6.05±4.86% (p=0.0128, n=4) again in comparison 
to the trough  depression of the initial  application of homoquinolinic acid  2~M. 
Each point shows the mean±s.e.m. for n=4 experiments. 
169 AMPA and kainate receptors 
The earlier paired-pulse data suggested that there might be a presynaptic 
component during the NMDA, HQA and QA evoked depressions of fEPSP 
slope.  AMP  A and kainate receptors are the main glutamatergic receptors 
responsible for basal synaptic transmission and the generation of currents 
underlying the fEPSP.  AMP  A and kainate were used at 100nM and 25nM 
respectively, concentrations that produced small depressions of the fEPSP 
slope.  In both cases, the application of Ro 25-6981  3  ~M  had no  effect on 
the responses,  confirming  that this  effect is  specific  to  NMDA receptor 
activation (figures 59 and 60).  This is consistent with the absence of effect 
of  Ro 25-6981 alone upon baseline responses. 
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Figure 59.  Effect of Ro 25-6981  and AMPA on fEPSP slope. 
Plot showing the effect of 100nM AMPA applied before and after the perfusion 
of 3IJM  Ro 25-6981, the response to AMPA was unchanged.  Each point shows 
the mean±s.e.m. for n=3 experiments. 
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Figure 60.  Effect of Ro 25-6981  and KA on fEPSP slope 
100 
Plot showing the effect of 25nM kainate applied before and  after the perfusion 
of  3IJM  Ro  25-6981,  the  response  to  kainate  was  unchanged.  Each  point 
shows the mean±s.e.m. for n=3 experiments. 
172 Discussion 
In order to  expose a response to the activation by homoquinolinic acid of 
the uncharacterised binding site reported by others the non-selective EAA 
antagonist kynurenic acid,  the competitive NMDA receptor antagonist 2-
AP5 and the non-competitive antagonist dizocilpine (MK-801) were used. 
2-AP5, as with some competitive antagonists (straight chain, piperidine and 
piperazine  structures)  displays  the  subunit  potency  NR2A  >  NR2B  > 
NR2D > NR2C (Laurie &  Seeburg,  1994).  However,  neither kynurenic 
acid,  2-AP5,  dizocilpine  nor  PEAQX  revealed  a  novel  action  of 
homoquinolinic acid on the fEPSP slope.  Therefore, the novel binding site 
for  homoquinolinic  acid  does  not  affect  acutely  recorded  synaptic 
potentials  in the hippocampus  and  homoquinolinic  acid  appears  to  be a 
selective agonist at NMDA receptors that include the NR2A subunit. 
Particularly when studied on fEPSPs, the paired-pulse paradigm represents 
a  valuable means of assessing the  actions  of compounds on presynaptic 
terminals.  The paired-pulse inhibition obtained at interpulse intervals of 
10ms  results  from  the  depletion  of transmitter  from  presynaptic  stores 
(Burke  &  Hablitz,  1994;  Wilcox  &  Dichter,  1994;  Hashimoto  &  Kano, 
1998), and is reduced by agents or procedures which decrease transmitter 
release.  Paired-pulse facilitation, observed at longer interpulse intervals, is 
due to  the residual intraterminal Ca
2
+  which increases transmitter release 
173 (Hess  et  ai.,  1987;  Wu  &  Saggau,  1994;  Debanne  et  aI.,  1996; 
Kleschevnikov et ai.,  1997).  The modification of paired-pulse interactions 
by homoquinolinic acid and quinolinic acid suggests that at least part of its 
ability to depress the fEPSP slope is presynaptic in origin.  Indeed, there is 
ample  evidence  corroborating  the  existence  of  presynaptic  NMDA 
receptors in several regions of the brain (Berretta &  Jones,  1996; Hamada 
et ai.,  1998; Glitsch &  Marty,  1999; Woodhall et ai., 2001), including the 
hippocampus (Breukel et ai.,  1998).  Alternatively, a retrograde signalling 
molecule  released  postsynaptically  in  response  to  depo1arisation  by 
homoquinolinic  acid  may  mediate  this  effect  indirectly  or  other 
postsynaptic effects may confound the changes in PPD and PPF (Foster & 
Richardson,  1997).  The possibility that adenosine released in response to 
neuronal depo1arisation could act as a retrograde inhibitor was investigated 
using the selective Al receptor antagonist DPCPX.  However, DPCPX had 
no effect upon the magnitude of the depression caused by homoquinolinic 
acid or paired-pulse interactions suggesting that the presynaptic activity of 
homoquinolinic acid is  not dependent upon the activation of presynaptic 
adenosine Al receptors. 
As previously seen with NMDA, Ro 25-6981 potentiated the responses to 
HQA and QA on fEPSP slope and altered paired-pulse interactions.  One 
possibility for the potentiating effect of Ro  25-6981  is  that it  causes an 
increase  in  the  release  probability  of glutamate  from  the  presynaptic 
174 boutons.  This is unlikely as there is no  effect of Ro  25-6981  on baseline 
ffiPSP  or  on  comparable  responses  to  AMP  A  and  kainate.  Another 
possibility is that Ro 25-6981  increases the local release of an endogenous 
NMDA  agonist  such  as  glycine,  homocysteate,  cysteine  sulphinate  or 
aspartate (Patneau & Mayer, 1990; Davanger et al., 1994).  Whilst glycine 
has a high affinity and is thought to saturate NRIINR2B receptors, it has a 
lower affinity for NRIINR2A receptors, which under resting concentrations 
of glycine could be unsaturated and may be potentiated with rising glycine 
concentrations. 
CCMQ was not able to  block the depression of ffiPSP  slope at a similar 
concentration at which it displaced the binding of HQA in binding studies. 
Furthermore, the Ro 25-6981-enhanced response to HQA was similarly not 
blocked.  This  suggests that CCMQ  is  not acting  as  an antagonist in its 
ability  to  displace  HQA  from  NR2A  subunits  in  the  previous  studies. 
Considering the slight, yet significant, increases in ffiPSP slope elicited by 
CCMQ under the influence of Ro  25-6981  it is  possible that CCMQ is  a 
weak  NR2A  agonist.  This  will  best  be  confirmed  using  recombinant 
NRIINR2A receptors expressed in Xenopus oocytes.  Once this has been 
achieved,  a  study  of structure-activity  relationships  could  lead  to  more 
potent and selective NR2A agonists. 
The absence of effect of zinc as  an NR2A antagonist may be due to the 
experimental  conditions  where  the  level  of NR2A inhibition  is  already 
175 saturated by the  concentrations  of zinc  contaminating  the  ACSF.  Also 
there may be physiological mechanisms that regulate zinc  inhibition still 
active  in  the  intact  slice  preparation,  such  as  tyrosine  kinase  src 
phosphorylation and chelation of zinc by thiol-reducing agents (Paoletti et 
al.,  1997; Arden et al.,  1998; Zheng et al.,  1998).  In addition, differences 
between native heteromeric receptors  and the recombinant receptors may 
weaken the effectiveness of zinc.  Zinc is concentrated by certain neurones 
into synaptic vesicles and can be released in a Ca
2
+ -dependent manner at 
some  synapses  including  the  mossy  fibre-CA3  pyramidal  synapse 
(Dingledine et al., 1999). 
The effect of the NR2A antagonist PEAQX demonstrates that the NR2A 
subunit-containing  NMDA  receptors  gate  the  currents  involved  in  the 
depression  of fEPSP  slope  and  the  associated paired pulse  interactions. 
The  enhancements  of paired-pulse  interactions  are  associated  both  with 
HQA  alone  and  under  the  influence  of Ro  25-6981,  where  the  NR2B 
subunit is  in both an activated and inhibited state.  This suggests that the 
NR2B  subunit  cannot  independently  alter  the  presynaptic  element 
suggested  by  paired-pulse  results  although  it  may  be  able  to  do  so 
indirectly  by  its  modulation  of NR2A  subunits,  which  alone  seems  to 
modulate  directly  the  enhancement  of paired-pulse  interactions  and  the 
depression of  the fEPSP slope. 
176 Chapter 6.  General Discussion 
Negative  coupling  of  NR2B  to  NR2A  subunit-containing 
receptors 
This  study  has  suggested  that  acutely  activated,  tonically  activated  or 
constitutively active NR2B  subunits maintain an inhibitory restraint upon 
the activation of  the NR2A subunit-containing NMDA receptors by way of 
a  protein  phosphatase  2B  (ca1cineurin)  transduction  step.  The  NR2A 
subunit-containing receptor seems to be the principal receptor involved in 
postsynaptic  depolarisation  and  presynaptic  alteration  of  release 
probability.  The NR2B subunit has no  observable function other than to 
gate the  activity  of the NR2A  subunit-containing  NMDA receptors.  A 
recent report  investigating the properties  of NRllNR2BINR2D receptors 
expressed  in  newborn  rat  hippocampal  granule  cells  has  also  observed 
evidence of negative coupling (Pina Crespo &  Gibb, 2002).  Additionally, 
NR3A subunits have been shown to negatively modulate NMDA receptors 
(Das et al., 1998).  Although the effect ofRo 25-6981  is dependent on the 
presence  of an  NMDA  receptor  agonist  to  observe  its  effect,  it  is  a 
persistent change in the weight of the synapse over a timescale reported to 
be  associated  with  a  potentiation  of  NMDA  (Watt  et  al.,  2004). 
Furthermore,  it  may  involve  co-incident  pre- and  postsynaptic  activity 
suggestive of a Hebbian process.  The NMDA receptor has a central role in 
177 the induction of LTP and LTD, the negative coupling demonstrated in this 
study has  significant implications for  determining  both the threshold for 
L  TP  and LTD  induction and perhaps the magnitude of plasticity induced. 
The  cellular  mechanism  by which  this  enhancement  is  produced  is  not 
entirely understood.  Such an enhancement has very exciting implications 
for our understanding ofNMDA receptor physiology and pharmacology. 
Multimeric NMDA receptor composition 
Nicotinic  acetylcholine  receptors  are  pentamers,  voltage-gated potassium 
channels  are  tetramers  and  gap  junction proteins  mediating  coupling  at 
electrical  synapses  are  hexameric  (or  hexamonic).  Glutamate  receptors 
were often supposed to  be pentamers because they, like the acetylcholine 
receptor are ligand gated.  Equal evidence exists for both a tetrameric or a 
pentameric  structure  from  receptor  subunit  studies  (Behe  et  ai.,  1995; 
Ferrer Montiel &  Montal,  1996; Premkumar &  Auerbach,  1997;  Laube et 
ai.,  1998; Mano  &  Teichberg,  1998;  Rosenmund et ai.,  1998).  However, 
these studies are designed to identify the number of  functional binding sites 
in a receptor but are based upon the assumption that each binding site in a 
receptor  operates  independently  of  other  subunits.  This  study  has 
suggested  that  there  is  a  negative  coupling  between the NR2A  and  the 
NR2B  receptor subunits and it has been reported by others of a negative 
coupling in receptors  containing NR3A and NR2A subunits  (Ciabarra et 
ai.,  1995; Das et ai., 1998) and NR2B and NR2D subunits (Pina Crespo & 
178 Gibb, 2002).  This observation suggests that the analysis of dose-response 
curves (Laube et al., 1998) and patterns of  main and sub-conductance states 
(Behe  et  al.,  1995;  Premkumar  &  Auerbach,  1997)  may  be  more 
complicated and the heteromeric  structure of the native NMDA receptor 
may have been miscalculated. 
Presynaptic NMDA receptors 
Demonstrating  the  role  of  presynaptic  receptors  definitively  ideally 
requires  the  fulfilment  of  five  criteria  (McGehee  &  Role,  1996; 
MacDermott et al., 1999): 
1.  Evidence for the presence of  presynaptic receptors. 
2.  Activation  of  these  receptors  exogenously  produces  the 
presynaptic  effect  that  alters  release  probability  (that  mimics 
physiological control). 
3.  Presence  of an  endogenous  ligand  at  the  synapse  that  can  be 
released  under  physiological  conditions  for  activation  of the 
presynaptic receptor. 
4.  Antagonists that block the presynaptic ionotropic receptors block 
synaptic plasticity. 
179 5.  Activation  of the  presynaptic  receptor  leads  to  the  observed 
change in release through a characterised mechanism. 
In answer to these criteria: 
1.  AMP  A, kainate and metabotropic glutamate receptors have all been 
established  as  presynaptic  autoreceptors  in  the  hippocampus 
(Vazquez  et al.,  1994;  Chittajallu  et al.,  1996;  A1ici  et al.,  1997), 
modulating  excitatory  transmission  by  altering  glutamate  release 
probability.  NMDA receptors have been amply demonstrated on the 
postsynaptic membrane (Petralia et al., 1994; Racca et al., 2000) and 
there  is  accumulating  evidence demonstrating  a presynaptic locus. 
Presynaptic  NMDA  autoreceptors  have  been  reported  in  the 
cerebellum (Glitsch & Marty,  1999), spinal cord (Liu et aI.,  1997), 
hippocampus  (Breukel  et  al.,  1998),  suprachiasmatic  nucleus 
(Hamada  et  aI.,  1998)  and  entorhinal  cortex  (Berretta  &  Jones, 
1996).  Furthermore,  presynaptic  NMDA  receptors  have  been 
reported  to  be  NR2B  subunit-containing  and  tonically  activated, 
causing an increase in glutamate release probability, dependent upon 
Ca
2
+  influx,  in  the  entorhinal  cortex  (Woodhall  et  aI.,  2001). 
Additionally, immunohistochemical studies have found evidence for 
presynaptic  NMDA  receptors  (Liu  et ai.,  1994;  Paquet  &  Smith, 
2000). 
180 2.  This report has suggested, through the changes observed in paired-
pulse interactions, that NMDA receptor activation by HQA, QA and 
NMDA generated an effect with a presynaptic element.  However, 
whilst  PPF  and  PPD  are  generally  accepted  to  be  presynaptic 
phenomenon,  it  does  not  follow  that  postsynaptic  effects  cannot 
influence their appearance in field recordings (Foster & Richardson, 
1997). 
3.  The endogenous ligand at these synapses is glutamate, which could 
act under physiological conditions to activate a presynaptic receptor. 
Furthermore, this study has demonstrated this effect by using another 
endogenous ligand quinolinic acid. 
4.  This  investigation has  demonstrated that both 2-AP5  and PEAQX 
can block NMDA-receptor dependent LTP.  Furthermore, it has been 
reported recently that Ro 25-6981 is able to inhibit LTD (Sjostrom et 
aI., 2003; Liu et at., 2004; Massey et at., 2004) 
5.  The  inhibition  of this  effect  by cyclosporin  A,  which  modulates 
protein phosphatase 2B (ca1cineurin) activity, demonstrates a distinct 
and well-characterised signal transduction pathway. 
The lack of sufficiently compelling evidence on point 2 in this study means 
that  there  is  not  full  qualification  for  a  presynaptic  NMDA  receptor. 
181 Therefore,  the  possible  involvement  of a  postsynaptic  receptor  with  a 
retrograde signalling mechanism must be considered.  In NMDA receptor 
dependent synaptic plasticity, postsynaptically induced processes such as 
LTD  and  LTP  are  still  able  to  trigger  presynaptic  changes  through 
retrograde messengers such as nitric oxide activating PKG (Reyes Harde et 
al.,  1999) and endocannibinoids acting upon CBl receptors (Cheval eyre & 
Castillo, 2003; Sjostrom et at., 2003) or release from other sources such as 
glia (Parpura et al., 1994). 
Whilst changes in paired-pulse interactions are widely regarded to  be due 
to  presynaptic alterations in release probability;  when studied on ffiPSPs 
and  especially  where  there  are  changes  in  the  size  of the  postsynaptic 
potential in response to the test agents many factors affect them which can 
affect  their  interpretation.  Including,  changes  in  presynaptic  release 
probability  (Andreasen  &  Hablitz,  1994),  activity  of  presynaptic 
autoreceptors  on inhibitory  or excitatory terminals  (Davies  et al.,  1990; 
Stanford  et al.,  1995),  modulation of postsynaptic  conductances  and the 
presence of  GABA-ergic inhibition following the ffiPSP and the depression 
cause by NMDA agonist action (Duguid & Smart, 2004). 
Also,  considering  the  intracellular  data  showing  a  purely  postsynaptic 
manifestation of  these effects a further study of  the contribution of  different 
NMDA  subunits  is  required  on  clear  presynaptic  phenomenon  such  as 
spontaneous  miniature  EPSPs  or  by  concurrently  measuring  by  patch-
182 clamp  whole  cell  recording  corresponding  presynaptic  and  postsynaptic 
neurones. 
It is  clear that NR2A and NR2B subunit-containing NMDA receptors are 
found postsynaptically, as NR1INR2A, NRIINR2B or NR1A1NR2A1NR2B 
heteromers,  at  the  synaptic  site  whilst  NR11NR2B  receptors  are  found 
exclusively at the extrasynaptic site (Li et at., 1998; Stocca & Vicini, 1998; 
Tovar  &  Westbrook,  1999).  A  tonically  activated  state  of the  agonist-
preferring NR2B subunit-containing receptor could be achieved by being 
located near to the release site of glycine and glutamate on the presynaptic 
bouton.  However, the NR2B  subunit in both it's activated and inhibited 
state is  associated with enhancements in paired-pulse inhibition whereas, 
only  the  blockade  of the  NR2A  subunit  prevents  the  enhancement  of 
paired-pulse interactions.  Alternatively,  the NR2B  subunit may be in  a 
constitutively active state that is independent of  agonist binding as has been 
observed  with  other  receptors  (Scheer  &  Cotecchia,  1997;  Behan  & 
Chalmers,  2001;  Richard  et  at.,  2001).  Interestingly  NR2B  subunit-
containing receptors have a higher glutamate and glycine affinity, are less 
sensitive to  tonic proton inhibition, and are insensitive to  desensitisation, 
which suggests that they would be more sensitive detectors of glutamate 
than NR2A subunit-containing receptors, especially at extrasynaptic sites. 
Applications  of HQA,  QA  and  NMDA  by  themselves  and  under  the 
influence of NR2B antagonism are associated with depressions of fEPSP 
183 slope  and  increases  in  paired-pulse  ratios.  These  are  both  blocked  by 
PEAQX,  the  NR2A  antagonist,  suggesting  that  the  presynaptic  element 
may be NR2A subunit-mediated.  It is  difficult from the current study to 
make any definitive resolution of the receptor populations found pre- and 
postsynaptically or the subunit makeup of such receptors. 
It may be possible to investigate these further using single channel analysis 
of outside-out patches from these tissues.  Using selective antagonists,  it 
can be determined whether the negative coupling of NR2B upon NR2A is 
between  subunits  in  a  single  heterotrimeric  NR1INR2A1NR2B  receptor 
(rather than between discrete heterodimeric NR11NR2A and NR1A1NR2B 
receptors).  This may also address the location of these subunits at pre- or 
postsynaptic sites.  There is evidence for the co-localisation of NR2A and 
NR2B subunits in the hippocampus, and specifically within the CA 1, CA2 
and CA3 regions (Fritschy et aI.,  1998). 
Excitotoxicity 
This report has demonstrated that, far from being neuroprotective, Ro  25-
6981  actually  precipitates  an  excitotoxic  insult  from  otherwise  benign, 
depolarising  concentrations  of NMDA  and  HQA.  This  observation  is 
contradictory  to  prevIOUS  reports  of  NR2B  antagonists  being 
neuroprotective  in  excitotoxic  studies  (Gotti  et al.,  1988;  Fischer  et  al., 
1997;  Lynch  et  al.,  2001;  Gill  et  al.,  2002)  but  some  reports  have 
184 corroborated this  study (Zou &  Crews,  2003).  The age of tissue used in 
investigations  could  account  for  the  reason  for  the  difference  in  these 
results.  In previous studies immature tissues were used whereas this study 
has  used  adult  tissues  in  a  well-proven  experimental  model  of 
excitotoxicity (Schurr et aI.,  1995).  As mentioned in the introduction, the 
expression levels and distribution of NMDA subunits change dramatically 
during  development,  especially  in  respect  of the  NR2A  and  the  NR2B 
subunits.  This developmental  change is  responsible for the alteration in 
susceptibility  of tissues  to  excitotoxicity  and  also  to  the  induction  of 
synaptic plasticity (Dudek &  Bear,  1993;  Liu  et al.,  1996).  The use of 
immature tissues to investigate excitotoxicity is dictated to some extent by 
methodological  constraints.  The rationale  for  using  these tissues  in the 
investigation of stroke,  which is  an  almost  exclusive threat to  the  adult 
population, is difficult to justify, especially here, considering the disparity 
between these results.  Additionally, the study of  tissue from different areas 
of the brain and even different regions of the hippocampus will dictate the 
influence of NMDA receptors  and  the  expression of different types  and 
quantity  of NR2  subunits.  A  recent  study  of cultured  hippocampal 
neurones reported that the selective activation of synaptic NR2A subunit-
containing  NMDA receptors  is  associated  with  the  potent  activation  of 
cAMP  response  element  binding protein (CREB)  and  subsequent brain-
derived neurotrophic factor (BDNF) gene expression.  This leads to an anti-
apoptotic  cell-signalling  pathway.  However,  the  activation  of NR2B 
185 sensitive  extrasynaptic NMDA receptors  by bath  application  of NMDA 
agonists  or  exposure  to  hypoxic/ischaemic  conditions,  which  cause  the 
reversal of  glutamate transporters (Rossi et al., 2000), is associated with the 
Ca
2+-dependent transient activation of CREB.  This leads to a CREB shut-
off signal  of the  synaptic  pro-survival  pathway  and  leads  to  cell  death 
(Hardingham  et  al.,  2002).  It  can  be  concluded  that  exceSSIve 
overactivation of the NR2A-subunit associated channel  could be directly 
responsible for the large Ca
2+ influx that triggers excitotoxicity.  The NR2B 
subunit acting to gate the activity of  the NR2A subunit-containing receptor 
and when it is inhibited this restraint is lost. 
An  obvious  question  anses  as  to  whether  there  a  correlation  between 
decreased levels of NR2B  subunit expression,  mRNA levels  and genetic 
expression in adult patients susceptible to stroke or in geriatric patients who 
have an  age-related susceptibility to  stroke and in other relevant disease 
states.  Indeed,  the NR2B  subunit is  already implicated in an impressive 
number of age related diseases and developmentally, the mRNA and the 
protein expression of  the NR2B subunit decreases significantly between the 
ages  of 3  and  30  months  in mice  (Magnusson,  2000;  Magnusson et al., 
2002) which is similar to the decrease in the human hippocampus (Law et 
aI.,  2003).  It is possible to  further develop this study by investigating the 
effect of selective subunit NMDA antagonists in hypoxia, ischaemia and 
seizure disorder, which are known to  have NMDA receptor components. 
186 The potential for the development of drugs to modulate this NR2B-NR2A 
interaction is very exciting. 
Phosphatase hypothesis 
This  report  has  suggested  that  NR2B  subunits  maintain  an  inhibitory 
control over NR2A subunit-containing receptors.  It could achieve this by 
being  acutely  activated,  tonically  activated  or  remaining  constitutively 
active  physiologically,  maintaining  the  phosphorylation  state  of  an 
unidentified protein.  The superfusion of Ro  25-6981  blocks  the NR2B 
subunit  leading  to  the  ca1cineurin-mediated  dephosphorylation  of  an 
unknown protein residue resulting  in the potentiation of NR2A subunit-
containing  NMDA receptor  responses.  NR2  subunits  are  known  to  be 
highly phosphorylated under basal conditions whilst NR1  subunits are very 
weakly phosphorylated (Lau  & Huganir,  1995;  Hall  &  Soderling,  1997; 
Smart,  1997).  Therefore, the dephosphorylation step  described here may 
be acting directly upon either the NR2A or the NR2B subunit to produce 
the enhancement of responses to NMDA and HQA.  However, it may also 
be acting on the NR1  subunit or associated proteins such as  PSD-95  and 
SAP  102  or an unrelated and possibly novel  site.  Interestingly, there is 
strong evidence for a tyrosine residue that is phosphorylated and leads to 
potentiation of the NMDA receptor and is  found on the NR2A or NR2B 
subunit-containing  receptor,  as  seen  with  insulin  potentiation  and  LTP 
(Chen & Leonard,  1996; Kohr & Seeburg, 1996; Rosenblum et al.,  1996; 
187 Smart,  1997;  Zheng et at.,  1998;  Christie et at.,  1999).  The absence of 
effect  of okadaic  acid,  a potent  inhibitor of the  serine/threonine protein 
phosphatases  types  1  and  2A,  rules  out  these  serine  residues  being 
involved.  The next step is to identify if there are changes in the levels of 
phosphorylation of these subunits.  This can be achieved by a combination 
of immunoprecipitation  using  NR1,  NR2A  and  NR2B  subunit  specific 
antibodies  to  these  proteins,  then  immunoblotting  with  anti-
phosphotyrosine and anti-phosphoserine specific antibodies and estimating 
changes  in  levels  of  phosphorylation  compared  to  controls  with  a 
chemiluminescent  secondary  antibody.  There  are  many  studies  that 
correlate increases  in phosphorylation with increases in receptor activity 
and that dephosphorylation is associates with reductions in receptor activity 
(Smart,  1997).  However,  it was  found  in this  study that the  activity of 
ca1cineurin, which de-phosphorylates is associated with the potentiation of 
responses to  NMDA.  This  is  blocked by Cyclosporin A,  a phosphatase 
inhibitor.  Many of the previous studies were carried out using immature 
tissue as with previous excitotoxicity reports as mentioned previously.  In 
addition  to  the  developmental  switch  of subunit  expression  (Tovar  & 
Westbrook,  1999) the basal levels of phosphorylation of the adult NMDA 
receptor do  not reach maturity until 3-4 weeks post-natally (Cudmore & 
Gurd, 1991). 
188 Synaptic plasticity 
The  entry  of calcium  into  the neurone  contributes  ~  16%  of the  NMDA 
receptor current but the subsequent activation of Ca
2
+  -dependent enzymes 
and signal transduction pathways induce potent effects (Schneggenburger 
et a!.,  1993).  Both LTP  and LTD  can  be induced by NMDA receptor 
activation,  resulting  in  an  influx  of Ca
2
+  that  triggers  plasticity.  The 
relative level, kinetics and location of the Ca
2
+ influx determining whether 
L  TP or LTD is induced; a large, fast,  synaptic influx inducing L  TP and a 
relatively modest, prolonged, extrasynaptic influx inducing LTD (Lisman, 
1989; Artola &  Singer,  1993; Neveu &  Zucker,  1996; Yang et a!.,  1999; 
Cho  et al.,  2001;  Liu  et al.,  2004;  Massey  et a!.,  2004).  The  receptor 
kinetics of the NR2B subunit-containing receptor is relatively slower than 
the NR2A subunit-containing receptor resulting in calcium influxes that are 
consistent  with  LTD  and  LTP  induction  respectively  (figure  61).  This 
suggests  that there is  a  role  of NR2B  in LTD that requires  an  NMDA-
mediated  influx  of Ca
2
+  consistent  with  the  NR2B  subunit-containing 
NMDA  receptor  kinetics.  Indeed,  it has  recently  been  reported  that 
neocortical  LTD  is  inhibited by NR2B  antagonists  affecting presynaptic 
receptors  (Sjostrom  et  aI.,  2003),  that  LTD  in  the  perirhinal  cortex  is 
inhibited  by the  NR2B  antagonist  Ro  25-6981  but  not  by the  NR2A 
antagonist PEAQX (Massey, 2003; Massey et al., 2004) and that LTD in 
the  hippocampus  is  NR2B  dependent  (Liu  et  al.,  2004).  The  NR2A 
189 subunit-containing receptor has kinetics consistent with those required for a 
large and rapid rise in intracellular calcium concentrations leading to  L  TP 
induction.  During  LFS  protocols  that  induce  LTD  the  NRIINR2B 
receptors make a larger contribution to  the total charge transfer and Ca
2
+ 
influx  whereas  during  HFS  protocols  that  induce  LTP  the  NRIINR2A 
mediates the greater total  charge transfer and Ca
2
+ influx (Erreger et aI., 
2005).  This  study has demonstrated that the NR2A subunit is  critically 
required  in  the  induction  of L  TP.  Furthermore,  it  is  known  that  LTP 
requires  protein  kinase  activation  (Malenka  et  aI.,  1989)  while  LTD 
requires protein phosphatase activation (Mulkey et aI.,  1993; Mulkey et ai., 
1994).  This  study  has  also  shown  that  the  protein  phosphatase  2B 
(calcineurin) inhibitor cyc1osporin A is able to prevent the effect of Ro 25-
6981.  This  is  consistent with reports  of calcineurin being  critical in the 
induction of LTD  (Mulkey et aI.,  1994).  This study cannot rule out the 
involvement  of  the  NR2B  subunit  in  Schaffer  collateral-CAl  LTP, 
especially  considering  the  interaction  of NR2B  with  the  critical  NR2A 
subunit-containing NMDA receptors  described,  the marginal reduction in 
L  TP induced and the many reports implicating the NR2B subunit in L  TP. 
This report has suggested that NR2B subunit-containing NMDA receptors, 
which have been reported to be tonically or constitutively active (Sah et ai., 
1989; Berretta & Jones, 1996; Breukel et ai.,  1998; Woodhall et ai., 2001) 
and are critically involved in the induction of LTD (Sjostrom et aI., 2003), 
190 negatively  gate  under  physiological  conditions  the  NR2A  subunit-
containing NMDA receptor.  It is widely reported and our studies have also 
found that successful NMDA dependent LTD induction is very difficult to 
achieve whilst L  TP  induction is  relatively easy (Kemp  & Bashir,  200 I; 
Massey et al.,  2004).  It could be that such tissues, rather than being in a 
resting state, are in a maximal LTD state and are therefore only able to be 
potentiated towards an L  TP state from which level they can then be easily 
depotentiated.  This could be explained by differential expression of NR2 
subunits in NMDA receptors.  This study has not demonstrated that there is 
a way to  increase the levels of the NR2B-mediated restraint and this may 
be because the level of restraint is  saturated.  A caveat to  this link is the 
exclusivity to the NMDA receptor and the requirement of NMDA agonist 
to  observe this phenomenon.  The induction of LTP  and  LTD  critically 
require  the NR2A  and  NR2B  subunits  respectively  but they  are  further 
associated  with  the  trafficking  of AMP A  receptors  to  and  from  the 
postsynaptic membrane and an associated change in the synaptic weight of 
neuronal transmission independent of NMDA receptor agonists (Malinow 
& Malenka, 2002; Watt et a!.,  2004).  This is missing from the interaction 
this  study has  shown but if bridged might lead to  the induction of L  TP 
proper. 
191 Donald Hebb's neurophysiological hypothesis states that'  When an axon of 
cell A is near enough to  excite a cell B and repeatedly or persistently takes 
part in firing it,  some growth process or metabolic change takes place in 
one or both cells such that A's efficiency,  as one of  the cells firing B,  is 
increased.' (Hebb, 1946). 
A  modification  of this  hypothesis  has  led  to  the  Bienenstock-Cooper-
Munro  (BCM)  theory  of the  sliding  threshold  of  synaptic  plasticity 
(Bienenstock  et aI.,  1982).  It hypothesizes  that  active  synapses  grow 
stronger or weaker when postsynaptic  activity  exceeds  or  falls  below  a 
'modification  threshold',  8m•  Presynaptic  activity  triggers  synaptic 
depression  or  potentiation  depending  on  the  concurrent  level  of 
postsynaptic  activity.  The  history  of integrated  postsynaptic  activity 
determines the threshold level at which plasticity is induced; the value of 
8m varies as a function of  the history of  integrated postsynaptic activity.  As 
average activity falls or rises, so does the value of  8m• 
This hypothesis led to the observations in the visual cortex that experience 
drives NMDA receptor subunit switching  from  LTD-induction-preferring 
NRllNR2B heterodimeric to  LTP induction-preferring NRlINR2BINR2A 
heterotrimeric  receptors  (Kirkwood  et aI.,  1996;  Philpott  et al.,  2001). 
NR2A and NR2B subunit-containing receptors provide the biological basis 
for the BCM sliding threshold of synaptic plasticity.  This model is further 
strengthened by the recent reports of  NR2A and NR2B antagonist sensitive 
192 induction of LTP  and LTD respectively (Liu et at.,  2004;  Massey et at., 
2004;  Mallon  et at.,  2005).  The negative  coupling  of NR2B  to  NR2A 
subunit-containing receptors may represent a further mechanism for fine-
tuning  the  strength  of NMDA  mediated  synaptic  transmission  and  for 
maintaining  a  threshold  for  induction  of synaptic  plasticity  that  only 
requires  changes  in  the  NR2B  subunit.  Perhaps  by  lateral  diffusion 
between synaptic and extrasynaptic sites, in agreement with recent studies 
where the NR2A subunit does not appear to  be very mobile (Groc et at., 
2004;  Triller &  Choquet,  2005).  Furthermore,  as  well  as  the  induction 
threshold for LTP or LTD induction there is also the magnitude of change 
in strength elicited (Castellani et at., 2001).  It was found in this study that 
whilst  LTD  could  not  be induced,  the  level  of LTP  that  was  reliably 
induced was of a particularly high magnitude.  A level at which it was then 
possible  to  depotentiate  from  (data  not  shown).  It may  be  that  the 
experience-deprived environment the rats are familiar with, means that the 
biological  basis  for  the  sliding  threshold  is  set  such  that  they  are  in a 
maximal  state of LTD  and that  only LTP  can be induced.  It has  been 
reported that rats  from  enriched environments are more likely to  exhibit 
LTD  (T.V.P.  Bliss,  personal  communication).  The investigation of this 
could help to discover more about the biological basis for the magnitude of 
synaptic plasticity induced and the effects of  environment (Castellani et at., 
2001). 
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Figure 61.  Phosphatase hypothesis. 
This scheme summarises the intracellular transduction systems that account for 
the  differing  pharmacology  and  physiology  of the  NR2A  and  NR2B  subunit-
containing  receptors,  the associated  phosphoprotein  steps  and  their influence 
over L  TP  and  L  TO.  In  brackets  are  the  relevant  antagonists  (Mulkey et al., 
1994; Revest & Longstaff, 1998). 
194 Appendix 1 
Methods 
Experiments  were  carried  out  by  Professor  T.W.  Stone  to  further 
investigate  the  actions  of  Ro  25-6981  using  intracellular  recording 
techniques. 
Intracellular recordings were made using sharp glass microelectrodes (o.d. 
1.5mm) (Clark Electromedical, Harvard Instruments).  These were pulled 
on a Narashige vertical puller in a manually controlled two-stage process to 
produce  pipettes  with  a  shank  length  of approximately  20mm.  The 
electrodes were filled with 1M potassium acetate, yielding a resistance of 
80-l00MO when measured in the extracellular space of the brain slices via 
the Neurolog amplifier.  Potentials were amplified by a Neurolog 102 DC 
amplifier or by  an Axoclamp-2A  operated  in  bridge  balance mode,  and 
filtered between DC  and 20KHz.  The electrode was  advanced in 2.51lm 
steps using a remotely controlled World Precision Instruments motorised 
stepper.  When a neurone was approached, indicated by a rise in electrical 
noise,  a brief increase  of electrode  capacitance  ('buzz') was  induced  in 
order to facilitate entry.  Cells were allowed to recover from penetration for 
at  least  10  minutes  before  examining  them  for  electrical  properties  and 
stability.  Neurones were then used for experimentation if they displayed a 
195 stable resting potential (±10% over 20  minutes) greater than 60m  V and a 
spike of at least 70m  V in response to an intracellular depolarising current 
pulse.  Current pulses  (OJ-InA) were used to  monitor membrane  input 
resistance throughout the experiments.  Records were calibrated using the 
amplifier's own calibration pulse (1 Om V), and were recorded directly onto 
a  high  frequency  thermal  chart  recorder  (Grass  instruments  Dash  IV), 
although the filter settings were placed at DC to 10Hz to reduce interfering 
transients and action potentials. 
196 Results 
NMDA 
Four neurones were tested with a combination ofNMDA and Ro 25-6981. 
In each case, NMDA was  superfused at a concentration of 2.5uM for  10 
minutes, with 20  minutes between each application.  At least two  control 
applications were made.  At this concentration, the cells showed little or no 
response, the two applications of  NMDA immediately prior to Ro 25-6981 
yielding barely discernible depolarisations of 0.19±0.048, 0.26±0.059mV 
(n=4).  Ten  minutes  after the  second  of these  controls,  superfusion  of 
Ro 25-6981  (3uM) was commenced for 20  minutes.  The next application 
of  NMDA (parallel with the second 10 minutes of Ro 25-6981) produced a 
similarly  weak  effect  (0.26±0.066m  V).  However,  the  next  application, 
which was begun 20 minutes after ending the superfusion of Ro  25-6981, 
produced  a  substantial  depolarisation  (l0.67±1.25mV;  p<O.OOOOl,  n=4) 
(figures 62  and 63).  This suggests that the negative coupling of NR2B to 
NR2A  subunit-containing  NMDA receptors  is  occurring  at  postsynaptic 
sites. 
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Figure 62.  Intracellular recordings of NMDA responses and the effect of Ro 25-
6981 
Intracellular recordings from  a pyramidal  neurone of resting  potential -74 mV, 
with input resistance  monitored  by  hyperpolarising  pulses of 0.3nA amplitude, 
300 ms  duration  every 20 s.  Recordings  are  from  one  of six  neurons tested 
with 2.5~M NMDA and  3~M  Ro 25-6981.  In panels a-c, NMDA was superfused 
alone at 2.5~M for ten minutes, with twenty minutes between each application. 
Ten minutes after record c,  Ro  25-6981  (3~M) was applied for twenty minutes. 
The next application of NMDA (d) (parallel with the second ten  minutes of Ro 
25-6981)  still  produced  no  clear  response.  The  next  application  (e,  twenty 
minutes  after  ending  Ro  25-6981)  indicates  an  increased  frequency  of 
excitatory  synaptic  potentials  elicited  by  NMDA,  while  in  panel  (f),  NMDA 
produced  a  substantial  depolarisation  with  superimposed  action  potentials 
(truncated). 
198 Figure 63.  Intracellular recordings showing the effect of NMDA alone and after 
the application of Ro 25-6981. 
Intracellular recordings from  a pyramidal  neurone of resting  potential -68 mV, 
with  input resistance  monitored  by  hyperpolarising  pulses of 0.3nA amplitude, 
300 ms duration every 20 s.  Recordings are from a second of the six neurons 
tested with  2.5~M NMDA and  3~M Ro  25-6981.  NMDA was superfused alone 
at  2.5~M  for  ten  minutes,  with  twenty  minutes  between  three  repeated 
applications (a).  Ten minutes after record the third  application had  ended,  Ro 
25-6981  (3~M) was applied for twenty minutes.  The next application of NMDA 
(parallel  with  the  second  ten  minutes  of Ro  25-6981)  still  produced  no  clear 
response.  The  next  application  (twenty  minutes  after  ending  Ro  25-6981) 
indicated  an  increased  frequency  of excitatory  synaptic  potentials  elicited  by 
NMDA,  while  in  panel  b,  a  further  application  of NMDA  (fifty  minutes  after 
ending  Ro  25-6981) produced  a substantial depolarisation with  superimposed 
action potentials (truncated). 
199 Appendix 2 
PEAQX is an NMDA receptor antagonists with a preference 
for the 1A12A, rather than 1A12B receptor composition. 
Y. P. Auberson*, S. Bischoff, K. Lingenhoehl, H. Neijt, M. F. Pozza, M. Schmutz 
PEAQX is  a  water-soluble quinoxalinedione with  a  high  affinity  for  the glutamate-
binding site of NMDA receptors (eH]CGP39653 binding assay:  IC50  =  I1nM).  At a 
concentration  of 10  /-lM,  PEAQX  showed  no  additional  activity  in  a battery of 68 
radio ligand binding assays for CNS receptors. 
In  vitro, PEAQX possesses a  126-fold selectivity for the NMDA  1A12A over  1A12B 
receptor  composition  expressed  in Xenopus  oocytes  (Figure  1,  IC50  =  14nM  and 
1800nM  respectively).  Experiments  on  embryonic  cortical  cells  and  on  neocortical 
slices  confirm  these  results  on  native  receptors:  Cultured  embryonic  cortical  cells 
express NR2A subunits at a very low level, resulting in a low potency of PEAQX (IC5o 
=  1 /-lM).  NR2A subunits are expressed to  a much larger extent in adult slices, and the 
effect ofPEAQX is therefore stronger in this model (IC5o =  68nM). 
Figure 1: Effect ofPEAQX on NMDA-induced currents in Xenopus oocytes expressing human NMDAR 
1A12A or 1A12B. Structure of(lRS,l  'S)-PEAQX. 
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In  vivo,  PEAQX is  a potent anticonvulsant in both DBAl2 mice (tonic  convulsions: 
ED50 = 1.2 mg/kg, 1h i.p.) and in the mouse maximal electroshock test (ED50 = 5 mg/kg, 
1h i.p.), with a long duration of  action (~24h). Anticonvulsant activity after intravenous 
administration indicates a rapid brain penetration. The side effect profile of PEAQX is 
clearly different from non-selective or NMDA 1A12B selective NMDA antagonists, as 
it causes no motor stimulation at anticonvulsant doses, does not disrupt the prepulse 
inhibition in the rat startle model, and does not substitute for PCP in rats trained in a 
two lever operant task. 
* K-136.6.82, Novartis PharmaAG, 4002 Basel, Switzerland. 
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